Wharton

MBA Program in Health Care Management

2015 RESUME BOOK Contents

Program Description ...... 4 Curriculum ...... 5 Graduates ...... 6-27 Internship Sponsors ...... 28 Health Care Program Mentors ...... 29-32 Administration ...... 33. Faculty ...... 34-35

Thank you for your interest in the Wharton MBA Program in Health Care Management . For further information, resumes, and appointments, contact:

June Kinney, Associate Director, MBA Program in Health Care Management The Wharton School University of Pennsylvania 3641 Locust Walk Philadelphia, PA 19104-6218

215 .898 .6861 | Fax 215 .573 .2157 email: aleszczc@wharton upenn. .edu

For information on the Wharton Health Care Management Alumni Association, visit www .whartonhealthcare .org

For detailed information on the Health Care Management Department educational programs, visit http://hcmg .wharton .upenn .edu/ 2015 Health Care Management

M .B .A . Graduates The University of Pennsylvania was founded by Benjamin Franklin in 1740 . Although the University carries the name of the Commonwealth, it is not a state university but an independent, private, nonsectarian institution . As one of the country’s earliest educational institutions, it has consistently initiated advances in teaching and research and has steadily generated specialized fields of higher education . Penn, as the University is commonly known, was the first American university to form departments of botany, hygiene and public health, surgical research, and research medicine . The University School of Medicine, formed in 1765, was the first in North America, as was the teaching hospital founded in 1874 . The world’s first psychological clinic was opened at Penn in 1896 .

The Wharton School, in the same spirit of innovation and excellence, was the world’s first collegiate school of business and management . Founded in 1881 with a gift from Joseph Wharton, the Philadelphia industrialist and philanthropist, the Wharton School undertook the pioneer steps in elevating training for business significantly above its previous level as noncollegiate commercial education . In 1921, the formation of the Graduate Program signaled the advancement of business administration at Wharton to the highest levels of professional education .

Today, the Wharton School has more than 270 faculty members teaching in both the graduate and undergraduate divisions and conducting a continually expanding volume of research . The 1,700 students in the master’s degree program may choose from among more than 200 courses and over 18 majors and concentrations, a variety reflecting the fact that the Wharton education complements the career goals of the individual .

This brochure is provided to introduce you to the 2015 Wharton Health Care Management Program graduates .

We encourage you to consider these individuals for employment .

3 Program Description

The Graduate Program in Health Care Management The Leonard Davis Institute of Health Economics is a full-time two-year MBA curriculum offered (LDI) is an interdisciplinary center for research by the Health Care Management Department of and education in the organization, financing, the Wharton School . The program, the principal and delivery of health care . Through LDI, University educational effort at the Leonard Davis Institute of Pennsylvania faculty and staff work together of Health Economics, is designed to provide on issues concerning health policy, health managerial and technical expertise to students insurance, managed care, hospitals, corporations, interested in the health care management field . pharmaceutical companies, and other health- By combining the skills of the Wharton disciplines related organizations . Established in 1967, the with sensitivity to the needs of health care providers Institute appropriately bears the name of the late and recipients, the Wharton MBA health care Leonard Davis, one of the foremost innovators in graduate can effectively manage the delivery of private health insurance in the United States . He health services and products at all levels . was the founder of Colonial Penn Group, Inc ., a company that has pioneered in insurance for older The Program has produced graduates who have Americans . Both Mr . Davis and Mrs . Sophie Davis chosen careers in hospitals and other medical were generous benefactors to the University of institutions, pharmaceutical, biotechnology and Pennsylvania, contributing basic support for the medical device companies, financial services, activities of the Leonard Davis Institute . entrepreneurial ventures, consulting firms, insurance firms, private health industry, and federal, state, and local government . Many of these MBA graduates now hold positions as chief executive officers, directors, and other key decision makers in health care organizations .

4 Curriculum The Wharton Management Core

All students are required to complete the Wharton Management Global Immersion Program Core . The Wharton School’s core curriculum is designed to The Wharton Global Immersion Program is an optional increase crossfunctional integration, extend global experience, half-credit elective course that provides first-year students strengthen leadership training, and introduce new courses with an in-depth exposure to international business on key management issues . The core curriculum provides practices and first-hand insights into a foreign culture . groundwork in basic management disciplines: economics, finance, financial and cost accounting, management science, The Health Care Major Courses and Electives managing people and organizational design, marketing, These courses promote an understanding of concepts, operations management, the governmental and legal institutions, and issues involved in the organization, environment of business, statistics, and strategy . financing, and delivery of health services and products in the United States . Health care electives are selected Fixed Core: consistent with individual career objectives and interests . • Foundations of Teamwork and Leadership • Marketing Management Required • Quality and Productivity • Health Services System • Regression Analysis for Business • Health Care Field Application Project • Microeconomics for Managers • Management Communication Electives • Comparative Health Care Systems Flexible Core: • Financial Management of Health Care Organizations Accounting • Managed Care, Market Structure, and • Financial Accounting or Health Care Delivery • Financial and Managerial Accounting or • Health Business and Policy • Accelerated Financial Accounting • Health Care Marketing • Healthy Policy Finance: Corporate Finance • Legal Aspects of Health Care • Corporate Finance or • Management and Economics of • Accelerated Corporate Finance or Pharmaceutical and Biotechnology Industry • Introduction to Corporate Finance • Medical Devices • Management of Health Care for the Elderly Finance: Macroeconomics • E-Health: Business Models and Impact • Macroeconomics and the Global Economic • Management of Health Care Services Businesses Environment or • Health Care Entrepreneurship • Introduction to Macroeconomics and the Global • Private Sector Role in Global Health Economic Environment • Health Care Services Delivery: A Managerial Economic Approach Legal Studies & Business Ethics • Advanced Study Project • Responsibility in Global Management or • Responsibility in Professional Services The Health Care Summer Internship The internship is a three-month management experience Management which provides the health care major an opportunity • Managing the Established Enterprise or to work with a senior executive in an organization of • Managing the Emerging Enterprise particular interest to the student .

Marketing MBA Electives • Dynamic Marketing Strategy or Opportunities are available for the health care major • Strategic Marketing Simulations to pursue a second concentration in fields such as entre- preneurship, marketing, finance, or operations, or to Operations pursue specialized knowledge in areas such as health care • Business Analytics or financing or within specialized segments of the health care • Information Technology and Business Transformation or industry including managed care organizations, hospitals, • Innovation or pharmaceutical and biotechnology companies, medical • Operations Strategy device companies, specialty services organizations, and • Communications long term care organizations . Graduate courses are • Advanced Persuasive Speaking or available throughout the University . • Advanced Persuasion and Data Display or • Pitching Your Business

5 Matt R. Adkins Neil Agarwal David Allen [email protected] [email protected] [email protected] Brown University, Providence, RI University of Maryland, College Park, MD University of Michigan, Ross School of Business, B .A ., Economics / Engineering, 2009 B S. ., Biochemistry, B .S ., Mathematics, 2008 Ann Arbor, MI Harvard Kennedy School of Government, B .B .A ., High Distinction, Cambridge, MA Finance and Accounting, 2006 M P. .A . Candidate, 2016

A commercial marketing opportunity An opportunity to use my strategic and An opportunity to build successful in the biopharmaceutical industry. operational expertise to improve value health care businesses through an in health care delivery. operational or strategic role. Pfizer, New York, NY Marketing Summer Associate, Summer 2014 Deloitte Consulting, New York, NY Medtronic, Northridge, CA Led the development of a full, Summer Associate, Summer 2014 Marketing Intern, Summer 2014 multi-channel, physician marketing Advised a major foundation in setting Designed and initiated a plan to evaluate campaign to announce the potential organization-wide strategy for $300M in and address cost-driven attrition in US approval of Palbociclib, one of health-related funding and investment . the United States for the Diabetes Pfizer’s most highly anticipated new Synthesized primary and secondary Business Unit . Developed a consumables drug launches . Presented recom- research into strategy white paper to marketing toolkit that was showcased mended content strategy to Business be used by other large foundations . at an industry conference in August Unit Review Committee to gain align- 2014 . Created the business case recom- ment on strategy from a regulatory Mount Sinai Hospital, New York, NY mendation for launch of a new infusion perspective . Worked with a creative Summer Administrative Resident, set in early 2015 . advertising agency to drive the execu- Summer 2014 tion of individual tactics and presented Recommended staff allocation modifi- Soros Fund Management, New York, NY proposed campaign directly to the cations that increased OR utilization by Private Equity Associate, 2010-2013 President of North America Oncology . 30% . Pinpointed margin contribution Member of the private equity group from surgeries using financial and at Soros Fund Management, the private Simon-Kucher & Partners, Boston, MA medical data . Analyzed ER care family office of the Soros family . As Senior Consultant, 2012-2013 processes to reduce wait times and part of a 16-person team managing a Consultant, 2009-2011 increase revenue . $3 5B. portfolio, primary responsibilities Pricing and marketing consultant for were to evaluate new investment clients in the pharmaceutical, biotech- Catapult Consultants, Arlington, VA opportunities and to manage portfolio nology, and medical device industries . Health Care Analyst, 2011-2013 companies in a variety of industries Led project teams of 2-9 consultants Worked with Medicare & Medicaid on including telecommunications, waste- on engagements providing clients with multiple engagements targeting care to-energy and healthcare . data-driven strategic recommendations quality in hospitals and nursing homes . on topics such as launch pricing, payer Developed data analysis tools; supported G.F. Capital Management and Advisors, contracting, forecasting, customer IT system design; created client trainings . New York, NY segmentation, messaging strategy, Only analyst invited to aid senior man- Private Equity Associate, 2007-2010 distribution strategy, and patient agement in new business development . $250M private equity fund focused assistance programs . Leveraged on media, entertainment, and quantitative analysis techniques U.S. Peace Corps, Bondo, Kenya branded consumer products . Evaluated including multivariate regression, Public Health Advisor, 2009-2011 and executed potential opportunities cluster analysis, and conjoint analysis Advised 4 rural hospitals on operational as the sole associate resource in the to drive strategic recommendations . improvements and recommended organization with responsibilities Presented reports and key recommen- changes to Health Ministry’s $1 .2M including: developing financial models, dations to client teams, including senior district budget . Created health leading due diligence sessions, management and C-level executives . education initiative reaching 2,500 coordinating third-party advisors, and students . preparing investment memorandums .

6 Joshua Atwood Brian P. Belsky Jonathan P. Brallier [email protected] [email protected] [email protected] Wesleyan University Yale University, New Haven, CT Franklin & Marshall College, Lancaster, PA B .A ., Economics and French Studies, 2008 B A. ., Political Science, 2007 B .A ., Cum Laude, Finance / Accounting, 2007 Harvard Kennedy School of Government M .P .A . Candidate, 2016

An opportunity to build successful The opportunity to build successful An opportunity to develop and execute companies in healthcare through businesses through health care focused innovative strategies to improve health strategy, business development, private equity investing. care ecosystems. or direct investing. Health Enterprise Partners, New York, NY Booz & Company (nka Strategy&), Albright Stonebridge Group, Summer Associate, Summer 2014 New York, NY Washington, DC Evaluated more than two dozen MBA Associate, Health Strategy Group, External Adviser, 2014 investment opportunities in healthcare Summer 2014 Advised multinationals on how best to services and IT sectors for firm’s $150M Developed product and go-to-market navigate complexities of investments second fund . Transaction experience strategy for the launch of a $5B and operations in emerging markets includes preferred equity investment consumer-directed business at a major through commercial diplomacy and in InDemand Interpreting, a provider health insurer . Determined company management consulting . Focused of video remote interpretation (VRI) and product positioning through on client service and business develop- services to the health care provider analysis of consumer data, competitive ment for finance and health care market . Worked extensively with offerings, and market trends . Designed sectors . multiple portfolio companies to amend an interactive financial operating cash management strategy and forecast model for the future-state business . McKinsey & Company, Boston, MA revenue bridge projections . Engagement Manager 2013 Falcon Capital Partners, Philadelphia, PA Senior Associate 2012 Self Health Network, San Francisco, CA Senior Associate, 2009-2013 Business Analyst 2010-2012 Chief Strategy Officer, 2013 Managed merger and acquisition, Research Analyst 2008-2010 Self Health Network is a readmission strategic advisory, and growth financing Led large consultant and client teams avoidance-focused health care technol- assignments in the health care and across over a dozen projects for lead- ogy company . Responsibilities included information technology industries . ing life sciences, financial services, and leading successful fundraising effort, Led investment analyses related to private equity firms . Worked closely cultivating sales pipeline, developing platform company investments on and built relationships with senior new product and preparing eight- behalf of private equity clients, including client management across industries, quarter corporate strategic plan . Warburg Pincus and Parthenon Capital . geographies, and cultures . Designed Directly managed client relationships and managed complex projects, Bank of America Merrill Lynch, during several sell-side transactions, creating client deliverables, conduct- New York, NY including advising clients on personal ing qualitative and quantitative Associate, Health Care Investment Banking, long-term goals and negotiating deal analysis, and coaching consultants 2010-2013 terms with clients and investors . and client executives . Provided financial, M&A and strategic advisory services to health care provider Morgan Joseph, Nashville, TN World Economic Forum, and managed care companies resulting Analyst, 2007-2009 Geneva, Switzerland in more than $1 .8B in completed Participated in the origination, analysis, Project Manager 2012 transactions in 3 years . and execution of merger and acquisition, Developed strategies and policy rec- fairness opinion, and general advisory ommendations for Ministers of Health, Merrill Lynch & Co., New York, NY assignments for clients in various Ministers of Finance, and industry Analyst, Tax-Exempt Capital Markets, industries, representing over $1B leaders on health system delivery and 2007-2009 in value . financing . Facilitated CEO and Minister Originated and traded credit products level discussions at the World for a Merrill Lynch proprietary fixed Economic Forum Annual Meeting income trading desk as well as third- at Davos 2012 as well as 10 other party clients . half-day workshops .

7 Colin W. Brown Alexandra C. Burtoft Elif Çar [email protected] [email protected] [email protected] The University of Chicago, Chicago, IL Lehigh University, Bethlehem, PA Bogazici University, Istanbul, Turkey B .A ., Honors, Philosophy, 2007 B S. ., High Honors, Bioengineering, 2008 B .A ., High Honors, Management, 2008 Harvard Kennedy School, Cambridge, MA M .P .A . Candidate, 2016

An opportunity to work at the intersection A promotional or strategic marketing An opportunity in consulting with of healthcare and technology to opportunity focused on oncology/ exposure to the healthcare sector. improve patient outcomes. hematology or rare disease within the biopharmaceutical industry. Alyuta, Istanbul, Turkey Infosys Limited, Pune, India Customer Development Manager, 2012-2013 Intern, Infosys Public Services, Summer 2014 Celgene Corporation, Summit, NJ Led a 4-person team to develop a Developed market-entry strategies to Hematology Marketing Intern. Summer 2014 cutting-edge marketing analytics tool support Infosys’s expansion into the US Evaluated and provided recommenda- for Turkey’s largest hospital chain and healthcare and government sectors . tions for potential commercial partner- e-commerce companies . Analyzed client Worked across sales, marketing, and ships with companies filing NDAs for data and made recommendations product development divisions to a drug to be used in combination with based on customer lifecycle analytics, modify existing IT solutions for US Revlimid . Spearheaded an evaluation next-product-to-buy, and customer market needs . of the current strategy for marketing lifetime value models . to hematology/oncology NPs/PAs and Clinton Health Access Initiative recommended specific tactics, as well Pfizer, Istanbul, Turkey Nairobi, Kenya & Kingston, Jamaica as increased spend/attention to this Product Manager, 2009-2012 Associate, Drug Access Team, 2011-2013 group . Used my commercial regulatory Project Manager 2008-2009 Analyst, Jamaica Country Team, 2010-2011 expertise to lead the creation, review, Responsible for developing and Advised government officials in the and ad agency collaboration for both executing cardiovascular products’ Caribbean and Sub-Saharan Africa consumer- and physician-focused business plans, including the cholesterol- on opportunities to reduce HIV treat- promotional tactics . lowering drug Lipitor . Developed ment costs and increase quality of care . launch plans for two different products Managed $3M grant covering programs Genentech Inc., South San Francisco, CA (Eliquis, Sevikar) including regulatory, and staff in Kenya, Uganda, Ethiopia, Associate Program Director, 2008-2014 reimbursement, pricing, and market- Tanzania, Nigeria, and Liberia . Worked for five years full-time and ing strategies by working closely with Collaborated with procurement for one year on a contract basis as the cross-functional partners . Planned and agencies and regulatory authorities promotional review committee (PRC) coordinated co-promotion business to accelerate the introduction of novel, lead for multiple brands, including models with Bristol-Myers Squibb and life-saving commodities and mitigate Boniva, Herceptin, Perjeta, Rituxan Daiichi Sankyo and led regular executive impending stockouts of HIV drugs . for RA, and Tarceva . Led the product meetings with country managers of launch for Perjeta and served as the both companies to ensure high level Accretive Health, Chicago, IL main commercial regulatory expert alignment . Developed Turkey’s first Lead, Measurement Team, 2008-2010 for cross-functional teams, including telemedicine project empowering Created complex financial models PR, brand marketing, managed care, physicians to track patients’ records to quantify the value of Accretive’s access solutions, medical affairs, remotely . Devised sales transformation revenue cycle initiatives . Improved corporate communication, commercial program for Norvasc (Turkey’s best accuracy of measurements allowed training, etc . Pioneered the “Creating selling anti-hypertensive), which the company to invoice and collect Perspective” training program to teach resulted in 20% unit growth and $22M on over $10M in outstanding revenue . sales representatives about the PRC sales . Identified growth potential in process and evolution of brand mes- diabetic patients for Lipitor by consoli- saging . The program was nominated dating market data with customer for a RethinkD Award for out-of-the insights and led diabetes projects box thinking for the betterment of resulting in increased treatment rates the company . of diabetics .

8 Daisy J. Carrillo Alli Chandra Dustin W.M. Chang [email protected] [email protected] [email protected] University of California, Berkeley, CA Harvard University, Cambridge, MA Johns Hopkins University, Baltimore, MD B .S ,. Industrial Engineering & Operations A .B ., Cum Laude, Government, 2010 B .A ., Economics and Psychology, 2008 Research, 2009

An opportunity to apply my business An operational, financial, or strategic An opportunity in private equity with and technical skill set to strategic and transformation role with provider exposure to the healthcare industry. operational roles focused on leveraging organizations transitioning to technology to lower costs, improve value-based care. Citadel Investment Group, New York, NY quality and increase access to care. Global Equities Summer Associate, McKinsey & Company, Washington, D.C. Summer 2014 Google, Mountain View, CA Business Technology Associate, Summer 2014 Initiated coverage or made recommen- gTech MBA Intern, Summer 2014 In first study, conducted market scan dations on five long/short positions . Developed a model to conduct a and fit-gap-analysis for claims product Developed detailed financial models global data analysis of Google’s tech- solutions for $1B government project to analyze potential investment nology support team, providing the that client is pursuing . In second study, opportunities . Conducted fundamental VP of Sales with strategic insights and developed framework and identified analysis through primary research; recommendations related to product target companies for $150M HIT led discussions with executive manage- adoption, growth trends, and support purchasing strategy for payer client . ment teams . capability gaps . Analyzed data to identify key drivers of unmet service Center for Medicare & Medicaid Galen Partners, Stamford, CT metrics, implementing 4 initiatives Innovation, Washington D.C. Associate, 2011-2013 that led to a 53% improvement in Special Assistant to the Director, 2012-2013 Healthcare private equity firm with total resolution time . Launched five payment programs approximately $1B AUM . Assessed worth $1 .5B under aggressive and analyzed investment opportunities Deloitte Consulting, Los Angeles, CA administration deadlines by negotiating across a range of transaction types, Consultant, 2009-2013 technical and press details with senior including growth equity, leveraged Primarily served health insurance leadership in HHS and the White House . buyout, and private investment in clients across multiple projects in public equity; proactively sourced technology strategy from operations Center for Medicare & Medicaid and screened investment opportunities . and process improvement to enter- Innovation, Washington D.C. Successfully completed five new or prise-wide system migrations for the Pioneer Accountable Care follow-on investments and one portfolio Health Insurance Exchanges . Delivered Organization (ACO) Program Officer, company sale . Advised portfolio a deployment strategy for a newly 2011-2012 company management teams on acquired health care benefit manage- Received Administrator’s Special strategic planning and business ment application, analyzing risks and Citation Award for exceptional work as development . benefits of 4 potential deployment operational lead and program officer options . Additionally, conducted a on Pioneer model . Served as sole Stifel Nicolaus Weisel, New York, NY / fit-gap analysis of the client’s customer Medicare representative to 10 major Baltimore, MD service team to determine the health systems . Co-led online peer Healthcare Investment Banking Analyst, operational impacts of using a new learning networks on data analytics, 2008-2011 application . Identified technical risk stratification, and predictive Ranked in the top quartile of analyst infrastructure needs, process redesign modeling . Crafted alignment algorithm, class . Analyzed companies using opportunities and training requirements . beneficiary overlap, attestation, audit, comparable company, precedent program monitoring, and reinsurance transaction, leveraged buyout, policies . Negotiated terms of ACO and discounted cash flow analyses . contracts with nine health systems Supported senior bankers in the for combined worth of approximately procurement and execution of three $10B . M&A transactions, eight financings that raised in excess of $1B in equity and debt capital and one valuation assignment .

9 Kelly C. Cheng Cyndi U. Chung Katherine A.A. Clark [email protected] [email protected] [email protected] Stanford University, Stanford, CA University of Pennsylvania, Philadelphia, PA Haverford College, Haverford, PA B S. ,. Management Science and Engineering, 2009 B A. ,. Summa Cum Laude, Phi Beta Kappa, B .S ., Honors, Chemistry, B S. ,. Mathematics, 2009 Biochemistry, English, 2010 Perelman School of Medicine at the University M S. ., Chemistry, 2010 of Pennsylvania, Philadelphia, PA Perelman School of Medicine at the University M .D . Candidate 2015 of Pennsylvania, Philadelphia, PA M D. . Candidate, 2015

An entrepreneurial opportunity to The integration of my science and An opportunity to apply my clinical, address healthcare challenges via business backgrounds to make health business, and research experiences technology innovations. care more accessible and affordable to a strategic role in medical device for patients. innovation. Augmedix, San Francisco, CA MBA Intern, Summer 2014 McKinsey & Co., Palo Alto, CA Becton Dickinson, Franklin Lakes, NJ Developed new platform strategy by Summer Associate 2014 Strategic Innovation Intern, engaging strategic hardware, software, Managed the transformation of clinical Medical-Surgical Systems, Summer 2014 content, and services partners . Initiated trial operations for a global pharma- Developed a business opportunity account development in Philadelphia ceutical company . Oversaw several strategy in medical oncology to identify metro region by pitching to 20+ health workstreams that planned and unmet clinical needs and managed a system CEOs, CIOs, CMIOs, etc . Designed monitored outsourcing to a contract direct report with full-time dedication and implemented hiring processes for research organization . to my project . 20+ engineering, operations, sales, and legal roles, doubling size of SF HQ . Perelman School of Medicine, Children’s Hospital of Philadelphia, Philadelphia, PA Philadelphia, PA Practice Fusion, San Francisco, CA Graduate Student Researcher, 2010-2014 Medical Student Researcher, Cardiology, Business Development Intern, Summer 2013 Conducted analyses on risk factors 2012-2013 Sized revenue opportunity for new for and outcomes after mandibular Studied implanted medical devices data analytics business line at $15M distraction osteogenesis, autologous modified to inhibit pro-inflammatory in near-term business, projected to breast reconstruction, and hernia events . Selected for a presentation at grow to $200M+ . Designed and tested repair, among other procedures . the Scientific Sessions of the American analytics prototypes with 35+ external Heart Association . Published manuscript health IT, life sciences, and health in Biomaterials . provider executives . Hospital of the University of Deloitte Consulting, San Francisco, CA Pennsylvania, Philadelphia, PA Consultant 2011-2013 Medical Student Researcher, Critical Care, Business Analyst 2009-2011 2012-2013 Strategy consultant for clients in Conducted interviews and synthesized provider, plan, life sciences, telematics, clinician surveys of a clinical decision software, and consumer products support tool for sepsis . Refined system industries . Assessed joint venture to result in a more sensitive alert . for integrated delivery network to Selected for an oral presentation develop artificial intelligence product at the Mid-Atlantic Healthcare with $107B global technology leader . Bioinformatics Symposium . Managed partnership development with $1 .4B voice recognition company . Hospital of the University of Modeled post-Health Reform market Pennsylvania, Philadelphia, PA changes to determine future areas of Medical Student Researcher, Interventional growth for $8B US health plan . Used Radiology, 2010 deliverables to co-develop a Health Conducted clinical research on Reform Market Offering . Hereditary Hemorrhagic Telangiectasia and central venous access devices . Selected for two presentations at European IR Society Conference . Published manuscript in the American Journal of Cardiology .

10 Michael J. Cromwell, IV Nicholas Y. Crowne Jennifer A. Dikan [email protected] [email protected] [email protected] University of Michigan, Ann Arbor, MI Harvard University, Cambridge, MA Tufts University, Medford, MA B .A ./B .B .A, with High Distinction, A .B ., Cum Laude, History, 2008 B .S ., Biomedical Engineering, 2008 Latin and Finance, 2008 Brown University, Providence, RI M .S ., Engineering, 2009

An opportunity to build leading An opportunity to identify, build, and An opportunity to apply my cross- healthcare businesses through transform market-leading companies. disciplinary background in engineering investment or management. and business in a strategic role focused Mount Kellett Capital Management, on developing innovative care models Castlight Health, San Francisco, CA New York, NY and disruptive innovations. Strategy Intern, Summer 2014 Summer Associate, Summer 2014 Analyzed 17 adjacent categories to Sourced, diligenced, and presented McKinsey & Co., Palo Alto, CA inform buy/build/partner decision- public and private equity and credit Summer Associate, Summer 2014 making for newly public healthcare opportunities across healthcare, TMT, Developed analytic models and technology company . Performed business services, and financial institu- recommended an investment plan research on third-party administrator tions . Led research process, including for improving women’s health as industry to identify disruptive growth analysis of unit economics, structural a part of the strategy for a global opportunities, and presented findings growth/decline, and investment health foundation . directly to CFO . Developed mergers catalysts to formulate investment and acquisitions template to serve theses and assess risk/reward . Natera, San Carlos, CA as valuation screening tool . Product Manager, 2009-2013 GTCR, Chicago, IL One of the first employees at Natera, Ascension Health Care Network, Associate, 2010-2013 a diagnostics company focused on New York, NY Originated and led $2B of private improving maternal and fetal health Director of Financial Planning and Analysis, equity transactions in healthcare through genetic insights . Led cross- 2012-2013 sector across 3 platforms, including functional decision-making across Directed due diligence processes for top-performing investment in Fund IX engineering, marketing, and sales to prospective hospital acquisitions with (Actient Pharmaceuticals), GTCR’s first develop a suite of prenatal genetic Oak Hill professionals, Ascension Health life sciences investment (Cord Blood testing products . Managed workflows subject matter experts, and outside Registry), and largest healthcare eq- across a team of 12 to ensure products consultants . Created multi-hospital uity investment (Sterigenics) . Identified and strategy were executed effectively leveraged buy-out model to evaluate attractive segments within healthcare and within executive management hospital consolidation opportunity sector, analyzed market attributes, and board expectations . Took insights with combined revenues of $1B+ . constructed detailed financial models, from the field through sales calls, orchestrated due diligence efforts, conference meetings, and grand Oak Hill Capital Management, and participated in board meetings . rounds presentations to inform New York, NY Executed five proprietary acquisitions product strategy and align priorities Private Equity Associate, 2010-2012 in 24 months to build Actient across teams . Performed due diligence, created Pharmaceuticals from management financial models and assisted portfolio start-up to successful sale ($645M) . company managers for private equity Partnered with management team firm with $3 .8B in latest fund . to acquire Cord Blood Registry and Executed transactions in home health worked alongside CEO to evaluate (AccentCare), radiation oncology strategic initiatives . (Vantage Oncology), and hospital (Ascension Health Care Network) Moelis & Company, New York, NY sectors . Analyst, Mergers & Acquisitions, 2009-2010

Barclays Capital / Lehman Brothers, Merrill Lynch & Co., New York, NY New York, NY Analyst, Media & Telecom Investment Healthcare M&A Analyst, 2008-2010 Banking Group, 2008-2009 Executed financial models to assess M&A transactions and capital structure alternatives .

11 Dean L. Drizin Christine Du David C. [email protected] [email protected] Fajgenbaum, M.D. Dartmouth College, Hanover, NH University of California, Los Angeles, CA A .B ., Salutatorian, Summa Cum Laude, B S. ., Biochemistry, 2007 [email protected] Government, 2006 Columbia University, New York, NY Georgetown University, Washington, DC University of Colorado School of Medicine, M A. ,. Biotechnology, 2010 B .S ., Magna Cum Laude, with Distinction, Aurora, CO Human Sciences, 2007 M .D . Candidate, 2015 Oxford University, Oxford, UK M .Sc ., Public Health, 2008 Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA M .D ., 2013 An opportunity to leverage my combined An opportunity in a strategic or consulting An opportunity to apply my clinical, skill set in medicine and management to role focusing on health care. research and business experiences improve health care delivery and patient to accelerate drug development for outcomes. Janssen Biotech Inc., Horsham, PA diseases with significant unmet needs. Experience Commercial Leadership Program University of Colorado, Department Intern, Summer 2014 Bristol-Myers Squibb, Plainsboro, NJ of Medicine, Aurora, CO Built and piloted specialty pharmacy Medical Strategy Intern, Summer 2014 Co-Investigator, Summer 2014-Present provider (SPP) performance dashboards Led initiative to identify data gaps and Implementing system changes via a for 3 brands: Simponi UC, Stelara, and design strategic projects for company’s multi-disciplinary, multi-hospital quality Zytiga . Developed and identified highest-selling oncology drug ($1 .4B improvement initiative to improve the leverage points along the patient in 2013) . Developed comprehensive patient care handoff process . fulfillment process for oncology and plan to overcome insurer restrictions immunology strategic imperatives to oncology drugs . Identified a risk to United States Navy, Bethesda, MD by working with 4 external partners, immuno-oncology field and proposed ENS, MC, USNR, 2011-Present 50 key stakeholders spread across risk-mitigation solutions . Medical education funded by the 10 business units within Janssen . United States Navy Health Professions Perelman School of Medicine, University Scholarship Program (HPSP) . Upon Corum Inc., Taipei Taiwan of Pennsylvania, Philadelphia, PA graduation, will serve as an active duty Sr. Marketing Executive, 2012-2013 Adjunct Assistant Professor of Medicine, physician in the United States Navy . Marketing Executive, 2010-2012 2014-Present Spearheaded the company’s strategic Member, Center for Orphan Disease KBL Healthcare, New York, NY plans, client management, legal Research/Therapy, 2013-Present Associate, 2007-2009 processes, technical investments; set Appointed faculty member in Division Sourced and evaluated potential global marketing strategy/product of Hematology/Oncology to conduct transactions; communicated with positioning and segmentations, increased clinical research and lead an interna- senior management of prospective company profits by 400x in 2 years . tional study as Principal Investigator . acquisitions; developed financial models; Initiated and oversaw new sales drafted letters of intent; prepared channels and new product indications Castleman Disease Collaborative company and investor presentations; in North America, EU, Latin America, Network, Philadelphia, PA assisted in management of portfolio China and Japan, ultimately leading Co-Founder & Executive Director, companies of KBL Healthcare Ventures to an over 20x increase in US sales 2012-Present revenues in 2012 . Developed interna- Launched global initiative to accelerate Banc of America Securities, New York, NY tional business opportunities in 25 drug development for Castleman Investment Banking Analyst, countries and planned 50+ product disease . Published research that Healthcare Group, 2005-2007 launches through global partnerships . caused a paradigm shift in the model Conducted qualitative and quantitative Trained, reviewed, and supported of pathogenesis . Established $4 .5M financial analyses for the healthcare 15 field sales reps and 30 distribution partnership with Janssen Pharmaceuticals services, medical technologies, and companies worldwide to establish to build a first-of-its-kind registry/ life sciences sectors for M&A, IPO, and 15 new Fortune 500 accounts, includ- natural history study . Direct 12-member capital raisings . Developed in-depth ing L’Oreal, Unilever, and Limited team and 23-member International quantitative modeling and transaction Brands in one year . Scientific Advisory Board . experience .

12 Zoe C. Farrell Danika M. Fry Jennifer L. Funk [email protected] [email protected] [email protected] Massachusetts Institute of Technology, Stanford University, Stanford, CA Georgetown University, Washington, DC Cambridge, MA B A. ., Sociology, 2007 B .S .B .A ., Summa Cum Laude, Accounting, 2008 B .S ,. Physics, B .S ., Biology, 2009 M A. ., Sociology, 2007

An opportunity to build successful An opportunity to advance health care An opportunity to work on a dynamic healthcare businesses through growth innovation through effective investment team within health care services, with equity investment and effective and strategic advisory. responsibility for both clinical operations management. and near-term strategy. Wells Fargo Securities, San Francisco, CA Apple Tree Partners, Princeton, NJ / Summer Associate, Healthcare Investment DaVita Healthcare Partners, Denver, CO New York, NY Banking, Summer 2014 Redwoods Summer Associate, Summer 2014 Summer Associate, Summer 2014 Provided M&A advisory to specialty Led a project exploring upstream patient Performed due diligence for two pharmaceutical, medical device, and education opportunities within hospi- investments that closed in Aug/Sep biotechnology companies . Developed tals . Determined how new kidney 2014 as part of the firm’s $1 .67B fund: marketing materials, conducted dili- patients are educated today on their Series A in the opioid treatment space gence, developed presentation materials, choices while in the hospital, through and Series B in the care coordination and provided process updates to client extensive secondary research and space . Developed healthcare IT during a sell-side divesture . Worked a dozen hospital visits across the investment thesis based on extensive with a biotechnology company’s country . Designed two in-hospital literature and field research . Worked C-suite to perform diligence for a patient education programs that with an entrepreneur-in-residence in private placement, and draft S-1 are now being piloted . the planning stages of a population for confidential IPO filing . Performed health management start-up . valuation analyses using public The Bridgespan Group, Boston, MA comparables, precedent transactions, Consultant, 2012-2013 Marwood Group, New York, NY and DCF . Senior Associate Consultant, 2011 Associate, 2013 Strategy consultant for non-profit Analyst, 2011-2012 Accenture, San Francisco, CA clients, with a focus on public health . Performed due diligence for private Consultant, 2010-2013; Analyst, 2007-2009 Worked with several public health equity clients making healthcare Advised healthcare, pension, and tech- foundations to define their five-year investments . Advised on commercial / nology firms on organization design, investment strategy at the enterprise government payor reimbursement training needs, and communication and initiative levels . Mentored and environments, legislative trends, and development . Select engagements: managed two junior teammates and Medicare / Medicaid policy changes . 1) created a project plan to drive was recognized as a finalist for office- Conducted primary and secondary reorganization of Biomedical Technology wide “Coach of the Year” award . market research for 100+ projects and Philanthropy business units for a in numerous healthcare subsectors . 29-hospital system . Negotiated biomed Bain & Company, Chicago, IL union contracts and directed relevant Senior Associate Consultant, 2010-2011 Boston Children’s Hospital, Boston, MA meetings with site management, Associate Consultant, 2008-2010 Genetics Researcher, 2009-2010 hospital administration, and HR . Strategy consultant across sectors, Conducted genetics research to Convinced 10 separate foundations with healthcare clients in hospital understand the orphan disease of to transfer funds to a consolidated services, pharmaceuticals, and claims nemaline myopathy . Co-authored account to achieve financial and administration . Project examples a paper published in a highly regarded managerial efficiencies; 2) engaged include cardiac service line and genetics journal . client executives across multiple business outpatient expansion strategies, units to gain buy-in for an organization merger integration, and process change strategy; 3) managed cross- redesign for financial forecasting . border team to develop and deliver training courses to internal and external stakeholders of a public pension fund .

13 Jin Ge Daniel E. Geoffrion Jeffrey S. Goodman [email protected] [email protected] [email protected] Princeton University, Princeton, NJ Yale University, New Haven, CT Harvard University, Cambridge MA B .S E. ., Magna Cum Laude, Phi Beta Kappa B A. ,. Economics, 2010 A .B ., Cum Laude, Economics, 2009 Chemical Engineering, 2008 Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA M .D . Candidate, Alpha Omega Alpha, 2015

An opportunity to combine my clinical An opportunity to apply my strategy An opportunity to help lower middle- and business experiences to transform experience to an operational role that market healthcare services companies care delivery to improve quality and gives patients access to quality services develop into industry leaders. outcomes. and/or devices. athenahealth, Watertown, MA Kaiser Permanente, Oakland, CA Medtronic, Minneapolis, MN Business Development Intern, Summer 2014 Performance Excellence Intern, Summer 2014 Corporate Strategy Summer Associate, Identified, researched, and assessed Developed metrics to measure end-of- Summer 2014 200+ prospective healthcare technology life quality at KPNC hospice agencies . Developed growth strategy for partnerships/acquisitions as part Conducted chart reviews and analyzed Integrated Health Solutions to quintuple of athena’s strategy to build out its variations in cost and outcomes at revenue by 2018 . Conducted deep inpatient revenue cycle and clinical KPNC medical centers to develop clinical dives in 6 European countries to software solutions . Met with manage- best practices . understand how patients and money ment teams of 35 companies to evaluate flow through each healthcare system their best-of-breed technology-enabled Becton-Dickinson Diagnostics, in order to best position and commu- services . Presented analysis and Franklin Lakes, NJ nicate value of Medtronic’s solutions recommendations on how select Strategy and Development Intern, portfolio . partnerships may support athena’s Summer 2014 effort to address key hospital pain Researched innovation thesis to serve Boston Consulting Group, Detroit, MI points . the biobanking industry . Modeled Associate, 2010-2013 costs, value creation potentials, and Enabled executives to solve key Waud Capital Partners, Chicago, IL revenue potentials for major players strategic issues . Projects led to the Associate, 2011-2013 in the sector . initiation of a hospital system merger Evaluated and assessed control-oriented ($7B combined revenue), sale of an growth equity investment opportunities AirCare, Philadelphia, PA auto supplier business unit ($500M in healthcare, business, and consumer Business Associate, 2013-2014 revenue), consolidation of 31 equity services out of the firm’s $463M Fund III . Assisted in fundraising activities for portfolios ($40B AUM), and delayering Collaborated with team of investment AirCare, a health IT startup focused ($20M savings) of a consumer goods professionals to close one platform on developing a communications and company . Responsibilities included investment, five add-on acquisitions, remote monitoring platform to reduce creating models, evaluating potential and two portfolio company debt hospital readmissions for patients targets, market sizing, designing financings . Partnered with management with CHF . decision trees, developing strategic teams of portfolio companies to create rationale, and communicating with business strategy, assess and structure The Boston Consulting Group, executives . strategic acquisitions, access financing New York, NY sources and develop corporate Senior Associate Consultant, 2008-2010 governance as a board observer . Developed a brand revitalization plan for a biopharma in the nutritional space . Bank of America Merrill Lynch, Identified cost-savings opportunities New York, NY in the post-merger integration of Analyst, Mergers & Acquisitions Group, preclinical and PK/PD units of two 2009-2011 biopharmas . Evaluated new product Contributed to client acquisition launch plans for a med-tech company, strategy through financial analysis, calculated an economic impact of valuation assessment, and company $400M . due diligence, resulting in four closed transactions .

14 Seema A. Gunda Jonathan D. Hahn Miles Hammond [email protected] [email protected] [email protected] Harvard University, Cambridge, MA Brown University, Providence, RI University of Pennsylvania, Philadelphia, PA B .A ., Chemistry, 2009 B A. ., Commerce, Organizations and B .A ., History, 2007 Entrepreneurship, 2010

An opportunity to improve patient An opportunity to build, grow, and An investing role with exposure to care through life sciences strategy. improve health care through strategy health care. or operations. Genzyme, A Sanofi Company, Glenhill Capital, New York, NY Cambridge, MA athenahealth, Watertown, MA Summer Research Analyst, Summer 2013 Business Development Intern, Summer 2014 Analytics Strategy Intern, Summer 2014 Identified and analyzed long/short Led initiative to define Genzyme’s Assessed athena’s analytics strategy equity investments in healthcare, investment strategy in Multiple for large enterprise clients and reviewed industrials, and telecom at a bottom- Sclerosis symptoms by prioritizing internal and external capabilities up fundamental long/short equity conditions and conducting a compre- to meet anticipated demand . Built hedge fund with $1 .6B AUM . Worked hensive asset scan . Collaborated with proof-of-concept reporting product, directly with Head of Research to R&D, Medical Affairs, Commercial piloted prototype to hospital executives, execute and monitor 4 investments Operations, and Market Access . and created roadmap for late 2014 during 12-week internship . Approach to be leveraged in multiple implementation . Conducted client business units . interviews, identified potential customer Enhanced Equity Funds, New York, NY segments, and created internal sales Private Equity Associate, 2010-2013 Leerink Swann, New York, NY message . Contributed to all aspects of investment Consulting Associate, 2011-2013 process at a healthcare private equity Consulting Analyst, 2009-2011 Amundsen Group – an IMS Health firm with $600M under management, Strategy consultant for pharmaceutical, Company, Burlington, MA which invests in lower middle market biotechnology, medical device, and Senior Associate Consultant, 2012-2013 healthcare services companies . financial clients with life sciences Associate Consultant, 2010-2012 Participated in 15 transactions across assets . Experience includes creating a Advised top 10 pharmaceutical 4 platforms and served on the Board loss of exclusivity strategy for a global companies on more than 15 projects of Primary Care Associates, a chain of pharma client . Built complex modeling focused on market access, marketing primary care clinics acquired in 2012 . tool to assess economic impact of strategy, and pricing/reimbursement various pricing scenarios on key issues . Responsibilities ranged from Barclays, New York, NY accounts, resulting in ~10% revenue client management to project Health Care Investment Banking Analyst, increase . Managed a team of five on management to heavy data analysis 2008-2010 a group-wide initiative to improve and modeling . Managed implementation Covered companies across life sciences, efficiency and overall experience of of novel analytics process and led healthcare services, and managed care . consulting group . communication across multiple Contributed to several closed transac- business units, tech divisions, and tions, including Sole M&A advisory on Sanford C. Bernstein, New York, NY external vendors for multi-billion Abbott’s acquisition of Solvay pharma Research Associate, Summer 2008 dollar respiratory portfolio . Analyzed for 4 .5B in 2012 . Ranked in top bucket Authored 35-page report on value marketing strategy and recommended during three out of four review cycles . of high-end consumer care products initiatives focused on patient acquisition . relative to low-end substitutes and Created new hire training program, impact on sector leaders during led case simulations, and streamlined recession . This report was distributed onboarding process for new hires, to 200+ clients and presented in leading to a two-thirds reduction in firm-wide meeting . training time .

15 Elizabeth C. Hansen Andrew D. Hedin Roberto L. Hernandez [email protected] [email protected] [email protected] Williams College, Williamstown, MA University of Pennsylvania, Philadelphia, PA University of Florida, Gainesville, FL B .A ., Cum Laude, Economics and Biology 2010 B A. ,. Biological Basis of Behavior, 2007 B .S ., Cum Laude, Computer & Electrical Engineering, 2007

A direct investing opportunity with An opportunity to operate and invest An opportunity to solve challenging exposure to the healthcare sector. in innovative health care companies financial, operational and strategy through venture capital or private equity. problems within health care. Putnam Investments, Boston, MA Equity Research Intern, Summer 2014 Health Essentials LLC, Santa Ana, CA Bank of America Merrill Lynch, Conducted fundamental due diligence MBA Operations Intern, Summer 2014 Palo Alto, CA on public and private healthcare Worked directly with the management Summer Associate, Technology Investment IT companies through product team of the healthcare services venture- Banking, Summer 2014 demonstrations, attending industry backed company . Collaborated with Provided M&A Advisory for technology conferences, HQ visits, hosting company clinical, operations, IT, and finance companies . Analyzed strategic meetings, and expert calls; developed as a project manager to launch dual acquisitions opportunities including market and company models . eligible coordinated care product . redomiciling targets . Managed buy-side Assessed population health software process and developed management Clarion Healthcare, LLC, Boston, MA vendors and led RFP process . presentations for a leading financial Consultant, 2013-2014 technology firm . Performed accretion/ Associate, 2010-2013 Fidelity Biosciences, Cambridge, MA dilution and valuation analysis using Advised a wide range of clients from Senior Analyst, 2012-2013 public company comparables, precedent biotechs to multinational pharmaceutical Analyst, 2010-2012 transactions, LBO, and discounted companies, contract sales organizations, Executed 16 new investments and cash flow . medical device companies, and private 9 follow-on investments in biotech, equity and venture capital investors . medical device, healthcare IT, and Harris Corporation, Washington, DC Project work included due diligence / healthcare services companies for a Project Manager, Dept. of Veterans Affairs, strategic transaction support (for venture capital fund with $1B under Veterans Health Benefit Enrollment manufacturers’ BD/New Products management . Led strategic, technical, Innovation Project, 2013 groups and PE/VC investors), sales regulatory, market, and financial due Reduced delays in the enrollment and force strategy and implementation, diligence efforts . Invested in private processing of veterans’ health benefits marketing innovation recommenda- startup companies (Series A – Series D) by designing, testing and deploying tions, and managed care strategy . focused on healthcare IT, ultra-rare improved software tools . Achieved Focused extensively on the quality diseases, novel technologies in emerging 15 .3% ROS, exceeding management’s of care incentives that providers are markets, specialty hospitals, cancer, expectation of 12%, by effectively facing as a result of healthcare reform ophthalmology, dermatology, and managing an 8 member team of and their implications for healthcare hospital equipment . Served as board analysts, software developers, and manufacturers and investors . observer for two portfolio companies . test engineers .

Leerink Partners, Boston, MA Business Development Manager, Associate, 2009-2010 Healthcare Solutions Team, 2010-2013 Analyst, 2007-2009 Built and fostered my organization’s Advised life sciences clients in over relationship with the US Coast Guard’s 20 consulting engagements in clinical Medical Division and guided that development strategy, commercial relationship to an $11M contract opportunity assessments, M&A award to provide our EMR installation strategy, product life cycle manage- and maintenance services . Engineered ment, and competitive landscape the technical specifications and features analysis . of a cloud-based electronic health record solution as a member of a multi-disciplinary team of engineers and medical specialists .

16 Luis M. Jones Ford Kerr Michael J. Kramarz [email protected] [email protected] [email protected] Stanford University, Stanford, CA Colorado College, Colorado Springs, CO Duke University, Durham, NC B .S ,. Biomechanical Engineering, 2006 B A. ., Cum Laude, Philosophy, 2007 B .S .E ., Summa Cum Laude, Phi Beta Kappa, M .S ., Mechanical Engineering, 2008 Biomedical Engineering, 2010 Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA M .D . Candidate, Alpha Omega Alpha, 2015

An opportunity to solve challenging An opportunity requiring entrepreneurial An opportunity to build leading problems in the health care industry. and strategic thinking within the health care companies using my context of mobile health, companion expertise in medicine and business. McKinsey & Company, Atlanta, GA diagnostics, or other disruptive forces Summer Associate, Summer 2014 with potential to make a significant Celgene Corporation, Warren, NJ Managed materials workstream on impact on the health care industry. Strategy Intern, Summer 2014 healthcare project that involved Worked in a strategy role within creating and monitoring a war room, Fitly, Philadelphia, PA Celgene Cellular Therapeutics (CCT), tracking key process metrics, and Co-Founder and CFO, Summer 2013-Present a wholly owned subsidiary of Celgene implementing process improvements Developed launch strategy, raised Corporation . Constructed long-range in order to assist the client in meeting $210,000 in seed funding, established plan for Organ & Tissue Therapeutics critical product delivery dates . strategic partnerships, and launched division . Assessed next-generation the company . Designed/implemented opportunities for placental-derived Medtronic Spinal & Biologics, Memphis, TN supplier operating model in 2 stores regenerative medicine platform . Senior Product Development Engineer, in 2 months, establishing a delivery Analyzed specific growth strategy 2010-2013 radius across 68 zip codes . Awarded for CCT’s umbilical cord blood bank, Designed and developed innovative admission into 3 competitive startup LifebankUSA . instruments to facilitate the insertion accelerator programs and won the of spinal implants by collecting and Wharton Venture Award . HealthpointCapital, New York, NY analyzing feedback from surgeons . Intern, Summer 2013 Led cross-functional team on strategic Booz & Company, Washington, DC Performed clinical due diligence for projects to develop custom implants in Senior Consultant, 2013 $35M acquisition target, assessing order to improve the lives of patients Consultant, 2011-2012 technology’s efficacy and indications . and convince competitive surgeons to Strategy consultant for pharmaceutical, Analyzed the competitive landscape, adopt Medtronic products . Completed biotechnology, and payer clients with detailing competitors’ products, pricing, the Medtronic Emerging Leader project experience in strategic launch and market positions . Developed Program (participants are chosen planning, strategic capability assessment materials for and participated in through a rigorous selection process and design, companion diagnostics Scientific Advisory Committee meeting that identifies high performing strategy, pipeline asset evaluation, regarding the acquisition . employees) . post-merger integration, and commer- cial opportunity assessments in the Children’s Hospital of Philadelphia, Covidien Neurovascular, Irvine, CA digital/mobile health space . Philadelphia, PA Quality Engineering Team Lead, 2008-2010 Research Fellow, Summer 2011 Managed team of engineers and Entre Todos (Microfinance Company), Conducted clinical research in the technicians that provided focused Buenos Aires, Argentina Department of Neurosurgery resulting quality support on micro catheters Loan Officer, Internal Consultant, 2009-2010 in poster presentation at annual production lines . Implemented process Worked as a loan officer with a portfolio American Association of Neurological improvements through the execution of 70+ clients, developed/implemented Surgeons meeting and publication in and timely closure of nonconformance client training programs to teach foun- Neurosurgery . Authored three textbook reports, maintenance and analysis of dational business skills, and co-led chapters on pediatric neurosurgical statistical process control charts, and the 6-month restructuring of a private topics published in Pediatric Cancer, completion of process validations on microfinance firm . Spine Surgery Basics, and Neurosurgical new equipment and fixtures . Post-Operative Monitoring and Complications .

17 Lindsay E.Y. Kuo, Jonathan M. Lanznar Christina S. Liao M.D. [email protected] [email protected] Emory University, Atlanta, GA Massachusetts Institute of Technology, [email protected] B A. . Psychology, 2008, Phi Beta Kappa Cambridge, MA Massachusetts Institute of Technology, S .B ., Brain and Cognitive Sciences, 2008 Cambridge, MA B .S ,. Biology, B .S ., Literature, 2006 Northwestern University Feinberg School of Medicine, Chicago, IL M .D ., 2010

An opportunity in strategy and business An opportunity to improve the quality, An opportunity to apply clinical and development at a growth stage health- efficiency, and experience of patient business knowledge to advance the care services or technology company. care at an integrated health system. quality of care patients receive. Quantia Inc., Waltham, MA Cedars-Sinai Health System, Center for Surgery and Health Strategy and Business Development Los Angeles, CA Economics, Department of Surgery, Associate, Summer 2014 MBA Intern, Clinical Transformation, Hospital of the University of Developed the go-to-market strategy Summer 2014 Pennsylvania, Philadelphia, PA for a new product targeting high-value Led 15-member cross-disciplinary task Research Fellow, July 2013-Present medical technology companies and force in developing the strategy and Performed outcomes research, primarily managed the initial sales team rollout . tactical roadmap for managing financial focused on endocrine surgery, and health Created models to project the market and clinical risk in new payer contracts . services research . Received a research size and value of additional physician Designed pilot program for e-visits and grant from the Society of American members; presented to executive presented recommendations to Gastrointestinal and Endoscopic team and insights incorporated into Medical and Clinical Directors to Surgeons . Presented at national fundraising strategy . Executed a gain operational buy-in . meetings . Multiple publications segmentation of clients and identified published in peer-reviewed journals . opportunities to reprioritize sales, Monitor Group, Los Angeles, CA marketing and partnership targets . Senior Consultant, Life Sciences, 2011-2013 Department of Surgery, Hospital Consultant, Life Sciences, 2010-2011 of the University of Pennsylvania, InterbrandHealth, New York, NY Advised top 10 pharmaceutical, bio- Philadelphia, PA Senior Consultant, 2013 technology, and medical device clients Resident in General Surgery, 2010-Present Consultant, 2011-2013 on marketing and organizational Responsible for all aspects of pre-, Associate Consultant, 2008-2011 strategies . Developed various product intra- and post-operative care . Currently Managed brand development programs positioning, segmentation, and physician at the post-graduate year 5 level . with cross-functional teams for 15+ messaging strategies for pre-launch Responsibilities include operating, clients across the healthcare industry . and in-line products . Designed and daily patient care decision-making, Programs ranged from product launched a global Center of Excellence and communicating with patients/ launches to mergers and acquisitions . in access and reimbursement for a families . Responsible for leading the Example projects include: creating $15B biotechnology firm . inpatient care team, including multiple the integration strategy for the merger junior residents and mid-level providers . of two medical device companies, The Walt Disney Company, Burbank, CA Experienced in surgical critical care coordinating the rollout of a new Financial Analyst, Business Planning & and cardiovascular surgical critical strategy for a diagnostic services Development for Parks & Resorts, 2008-2010 care . Experienced in diagnosis and company while growing the account Conducted financial modeling and treatment of vascular, thoracic, from $600,000 to $2M, and consolidating due diligence research on potential endocrine and oncologic, bariatric, a headache market segmentation to acquisition targets in the travel and colorectal, minimally invasive, trauma, identify core prime prospects to leisure sector . Led market sizing, and general abdominal surgery . achieve an $18M yearly growth target . profitability benchmarking analysis, Responsible for medical student and consumer segmentation for teaching integrated into all aspects annual business line reviews with of clinical surgery . more than 20 finance and operations leaders .

18 David E. Light Ethan I. Lipkind, J.D. Patricia J. Liu [email protected] [email protected] [email protected] Princeton University, Princeton, NJ Northwestern University, Evanston, IL University of Pennsylvania, Philadelphia, PA A .B ., Magna Cum Laude, Chemistry, 2007 B A. ., Political Science, Slavic Studies, 2006 B .S ., Magna Cum Laude, Management Boston University School of Law, Boston, MA & Operations Management, 2010 J .D ., 2009

An opportunity to grow a company An opportunity to create value for An opportunity to pursue strategy and in the wellness, nutrition or biopharma- healthcare businesses through private marketing to impact consumer health ceutical sectors through a direct equity investing or strategy role. and nutrition within the retail sector. investing, strategy or operations role. Cressey and Co., Chicago, IL Walmart eCommerce, San Bruno, CA Biogen Idec, Cambridge, MA Summer Associate, Summer 2014 @WalmartLabs Mobile Strategy Intern, New Product Commercialization Intern, Engaged in all aspects of healthcare Summer 2014 Summer 2014 services investment processes including Evaluated mobile trends and features As a member of the launch strategy due diligence, modeling, and financing . for Walmart to prioritize going forward . team for an asset in Phase III, led a Advised investment committee on Assessed iPad app performance across project to develop a strategy and healthcare services trends and sector the business portfolio to identify identify tactics to improve the effi- opportunities, leading to 2 new invest- strengths and pain-points . Hosted ciency of diagnosis of a rare, neuro- ment theses . business development meetings with muscular condition . Worked with entrepreneurs interested in partnering cross-functional internal partners, Complete Healthcare Management, with Walmart in the mobile technology sourced and managed external Chicago, IL space . Conducted research across consultants, conducted primary Principal, 2011-2014 competitor mobile grocery apps to research, and presented recommenda- Provide legal, compliance, and understand desired functionality in tions directly to division Vice President . management services to physician preparation for the Walmart To Go practices and hospitals; sample (grocery delivery) app launch . Putnam Associates, Burlington, MA transaction: formed multi-specialty Senior Consultant, 2012-2013 group by merging neurosurgery and Deloitte Consulting, New York, NY Analyst, Associate, Senior Associate, interventional radiology physician Consultant, 2010-2013 Consultant, 2008-2012 practices and launched stand-alone Provided strategic and managerial Led strategic consulting projects for six diagnostic medical imaging center guidance for companies across both top 15 pharmaceutical companies, and to capture revenues from new group’s the health care and retail industries, three top 10 biotechnology compa- referrals . with project work focused on customer nies . Areas of project focus include and market insights . Sample projects: oncology, hematology, neurology, Michigan Rural Healthcare Preservation 1) performing a deep-dive on stake- infectious disease, and health IT . Project Holding Co., d/b/a Michigan Clinic, holder influencers to improve provider responsibilities included creation of Chicago, IL and MI targeting and segmentation for a detailed forecast models, patient and CEO, Director, 2009-2013 pharmaceutical company; 2) enabling physician strategic segmentation for Managed over 400 employees . Oversaw international growth initiatives by marketing activities, design of payer operations and growth of health care reprioritizing budget allocations and contract terms, recommendation on provider holding company; responsible discretionary spend for a medical tactics for engagement with patient for all investment and corporate devel- device company 3) analyzing consumer advocacy, structuring pharmaceutical opment decisions . Sourced, financed, purchase habits and marketing distribution contracts, and recommen- structured, and executed acquisition effectiveness for an ecommerce dations on clinical development plans . of 2 community hospitals . Organized retailer; 4) developing a predictive As a manager, trained, developed, network affiliations with multiple scorecard to enable store expansion and oversaw 30+ junior team members physician practices, a research institute, for a global retailer . (~ 4-5 per project) . and a medical school . Turned around hospital from perennial operating Merck & Co., Rahway, NJ losses to highest net patient revenues Associate Chemist, 2007-2008 and earnings in its 60-year history; Designed and synthesized over 100 doubled hospital assets, increased novel small-molecule drug candidates operating revenues 154%, decreased based on structure-activity data and liabilities 45% . spectroscopic analyses . Contributed to patents for two drug candidate scaffolds . 19 Wei (Lluvy) Liu Sofya Lyashko Duncan Mackay [email protected] [email protected] [email protected] Peking University, Beijing, China Novosibirsk State University of Economics Duke University, Durham, NC B .A ., History, 2009 and Management, B .S ., Cum Laude, Novosibirsk, Russia, B .A ., 2005 Neuroscience and Psychology, 2007 Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA M .D . Candidate 2015

An opportunity in management An opportunity in pharma/biotech An opportunity to integrate my medical consulting or international business strategy analysis or health care and business expertise to improve design development focused in healthcare. consulting. of health care delivery systems.

The Boston Consulting Group, McKinsey & Company, Moscow, Russia University of Pennsylvania Health System, Shanghai, China Associate, Summer 2014 Philadelphia, PA; University of Pittsburgh Summer Consultant, 2014 Worked with a client team to run Medical Center, Pittsburgh, PA Co-developed subsidiary role classifica- analysis and develop opportunities Sub-Internships in Plastic Surgery, tion system and management guidelines to increase revenues . Summer 2014 for the governance of overseas Acting intern on plastic surgery service, subsidiaries for a leading global ICT TMK, Moscow, Russia treating patients, assisting in surgery solutions provider head quartered in Head of Financial and Economic Analysis across the spectrum of the plastic China . Conducted benchmark study Department, 2011-2013 surgical field, including general recon- on foreign subsidiary management Led a team of analysts to perform structive surgery, trauma reconstruction, of 4 global technology conglomerates, analysis of economic and operational breast reconstruction, craniofacial presented findings to the head of performance of the company with a surgery, cosmetic surgery, and hand Investment Management Department, $7B revenue for the needs of investors surgery . Active in clinical and basic and received high remarks . and management . Built valuation science research . model for a company’s acquisition . B.Braun Medical, Beijing, China Developed and implemented plan for Friends of NOAH, USA, Hershey, PA Key Account Supervisor, 2012 a pre-acquisition debt restructuring . Co-founder, Director 2009-Present Senior Sales, 2010-2011 Friends of NOAH USA, (Nurturing Developed sales strategies to increase Ernst & Young, Moscow, Russia Orphans of AIDS for Humanity), is market penetration, doubling sales Manager, 2005-2011 a grassroots nonprofit designed to revenue and market share of previous Led a team of auditors focused on help communities raise their orphaned year . Designed key account manage- serving pharmaceutical companies children by providing physical, educa- ment model to optimize resource and healthcare providers . Awarded tional, and psychosocial support to the allocation and created performance as a manager of the best audit project extended family network of children improvement initiatives to enhance in 2010 . Achieved 25% reduction in in South Africa who have been orphaned sales team productivity . Received full the project time and 60% growth in by AIDS . Co-ran the organization, built score in annual performance evaluation the project’s profitability . Designed and ran online presence, organized with fast-track promotion and awarded audit procedures that were included annual fundraisers, researched and “Best Sales”, “Early Bird”, “Key Account in the monthly emails distribution as assessed our practices and outcomes . Management Champion”, and “Excellent best practices examples . Was elected To date, we have raised over $120,000 New Employee” . by the company’s senior management and care for over 250 children . to the board of experts . Johnson & Johnson Medical, Bain & Company, Chicago, IL Beijing, China Associate Consultant, 2007-2009 Sales Management Trainee, 2009-2010 As a strategy consultant, structured Managed sales at the largest and performed analyses that drove cardiovascular hospital key account in impactful recommendations for China . Established strategic partnership Fortune 500 clients . Built financial with industry key opinion leaders and models, assessed and recommended enhanced clients’ clinical expertise M&A targets, developed research with physician education programs . tools, assessed and implemented Awarded “Best Project Execution” . executive culture and communication improvements .

20 Amit A. Mahadevia Kristen E. Carlo Martelossi [email protected] [email protected] Yale University, New Haven, CT Manderscheid Bocconi University, Milan, Italy B .A ., Psychology / Behavioral Neuroscience, 2008 [email protected] B .B .A ., M .S ., Finance, 2011 Duke University, Durham, NC B S. ., Magna Cum Laude, Economics, 2010

An opportunity in strategy or An opportunity to develop and refine An opportunity to make an impact business development at a biotech global pricing and market access and create value through operational or pharmaceutical company. strategies for select pipeline assets. improvements.

Celgene Corporation, Summit, NJ Biogen Idec, Cambridge, MA Zalora, Jakarta, Indonesia Global Marketing Intern, Summer 2014 Pricing & Reimbursement Strategy MBA Marketing Intern, Summer 2014 Designed and executed an NPV Intern, Summer 2014 Designed and implemented new analysis to assess commercial value Led a project examining the financial processes for promotional campaign of an internal asset and biomarker and strategic impact of federally development and customer relationship strategy in a large lymphoma indication . mandated 340B drug discounts on a management teams, creating new Worked closely with clinical team to pipeline asset, to inform U .S . launch roles, clarifying responsibilities, and design clinical trial scenarios to support planning . Supported the P&RS group introducing new incentive schemes . development of asset . Analyzed by providing pricing estimates for an Developed segmentation for Zalora’s development opportunity of a pipeline early-stage pipeline asset across three 200,000 customers in Indonesia based asset in a niche lymphoma indication targeted indications, to inform indication on identified main drivers of purchasing not currently addressed, including prioritization and global commercial behavior and launched pilot to evaluate review of treatment process and forecast . Helped manage an external the effectiveness of newsletters competitive landscape, and recom- vendor conducting primary payer tailored to customer preferences . mendation of how to optimize value research in U .S . and Germany, to of the asset . Created global messaging understand value drivers and pricing The Boston Consulting Group, platform based on results of a ran- potential for pipeline drug . Milan, Italy domized clinical trial and collaborated Associate, 2011-2013 with US and global marketing leadership Deloitte Consulting, Boston, MA Identified and launched strategic to validate and deliver messages . Consultant, 2012-2013 pricing initiatives in Germany, France, Analyst, 2010-2012 and Spain for major American medical ZS Associates, Boston, MA Strategy and operations consultant device manufacturer as part of the Consultant, 2012-2013 focused primarily on pharmaceutical redefinition of the go-to-market Associate Consultant, 2010-2012 clients . Responsibilities included model leading to $25M bottom-line Business Associate, 2008-2010 strategic advisement, analytical model impact . Performed competitive analysis Sales and marketing strategy consultant development, process design, and and quantitative assessment of the for pharmaceutical, biotech, and medi- project management . Major projects Italian Generics market in strategic cal device companies . Managed teams were: future-state design of global due diligence on pharmaceutical of associates in conducting qualitative quality control processes within clinical company for top private equity firm . and quantitative market strategy trial data management; development Defined new customer segmentation engagements . Moderated qualitative of a U .S . brand planning tool to and targeting strategy for top interviews with physicians (across effectively manage marketing spend European corporate and investment many specialties) and patients . Designed for client’s top 25 U S. . commercial drugs; bank based on opportunities for cross- and analyzed quantitative research and creation of business analytics to selling of high-value-added products instruments to inform commercial track effectiveness of a global data resulting in $50M increase in revenues . strategy . compliance project across 57 countries and 5 third-party vendors . Deutsche Bank, Milan, Italy Investment Banking Intern, Fall 2010 Managed coverage activities on clients in the consumer, retail, industrial and healthcare sectors .

21 Caitlin L. McAuliffe Lisa E. Perlmutter Gordon I. Phillips [email protected] [email protected] [email protected] Yale University, New Haven, CT Washington University, St . Louis, MO Williams College, Williamstown, MA B .S ,. Cum Laude, Molecular Cellular B A. ,. College Honors, Psychology, 2009 B .A ., Math & Economics, 2008 and Developmental Biology, 2005 University of Pennsylvania School of Medicine, Philadelphia, PA M .D . Candidate, 2015

An opportunity to apply my medical An opportunity in strategy, operations, A health care finance role in banking, and business experience to improve or business development to improve private equity or business development, patient quality of care. value in health care delivery. leveraging my prior operational and strategic experience. University of Pennsylvania Health Aetna Accountable Care Solutions, System, Philadelphia, PA Hartford, CT Raymond James, Nashville, TN Research Assistant, Department of Product Strategy/Market Intelligence Intern, Associate, Summer 2014 Orthopaedic Surgery, 2011-2014 Summer 2014 Led teams in the execution of multiple Critically examined precipitating Member of team forging innovative M&A processes, the creation of mar- factors for unplanned admission to partnerships and insurance models keting materials and the underwriting the intensive care unit following with providers . Developed business of $140M in capital raises for middle- arthroplasty . Spearheaded due diligence case and new product concept for market health care services businesses, process in preparation for first published comprehensive at-home care solution primarily in the behavioral health and study, simultaneously laying ground- to help providers lower the total cost hospice industries . work for multiple subsequent studies, of care . Created due diligence model with ultimate goal of maximizing to evaluate one of Aetna’s business CVS Caremark, Woonsocket, RI patient safety and clinical quality strategies and the viability of a new Senior Analyst, 2011-2013 in joint replacement surgery . solution in three markets . Designed and implemented a new chain-wide service guiding patients Walter Reed Army Medical Center, The Advisory Board Company, and doctors through the process of Washington, DC Washington, DC switching from a 30- to 90-day supply Research Assistant, Center for Neuroscience Senior Analyst, 2012-2013 of select maintenance medications, and Regenerative Medicine, 2009-2010 Research Analyst, 2010-2011 increasing prescription drug adherence Investigated traumatic brain injury, Completed four best-practice research by 15% for converted patients and spinal cord injury, phantom limb pain studies and several web conferences converting over 1M patients in first and other sequela of amputation . for a client base of 400+ senior hospital 12 months of program operation . Participated in several original research executives . Analyzed primary and Leveraged this capability to retain projects by writing research protocols, secondary research into actionable Walgreens patients during the participating in the Institutional strategies for hospital executives on Walgreens-Express Scripts dispute . Review Board process, and assisting topics including clinical quality perfor- with the execution of protocols . mance, physician engagement and Monitor Company Group, Cambridge, MA contracting, physician leadership Senior Consultant, 2008-2011 Walter Reed Army Medical Center, development, ICU management, and Led teams in the creation of pricing, Washington, DC use of advanced practice providers . growth, and partnership strategies Clinical Research Assistant, Physical Medicine Developed tools to help clients for a variety of corporations across and Rehabilitation Service, Summer 2008 implement best practice strategies, the pharmacy, insurance, and pharma- Treated multiple amputee patients including ROI analysis of palliative ceutical industries . Examples include with experimental mirror therapy care and a toolkit for improving the creation of an econometrically- designed to reduce phantom limb pain . project management skills . derived Medicare prescription drug plan pricing strategy for a national health insurer and prioritizing the development of pharmacogenomics revenue streams for a leading pharmacy benefits manager .

22 Visali V. Ramanathan Emily T. Reid Matthew B. Ritz [email protected] [email protected] [email protected] Harvard University, Cambridge, MA University of California, Berkeley, CA Georgia Institute of Technology, Atlanta, GA A .B ., Cum Laude, Molecular & Cellular Biology, B A. ., Honors, Public Health, 2008 B .S ., Highest Honors, Management, 2007 2010

An opportunity to identify and build An opportunity to build and grow A direct investing opportunity with successful life sciences companies a health technology company. exposure to the healthcare sector. through a business development or investing role. Castlight Health, San Francisco, CA Cornerstone Investment Partners, Product Marketing Intern, Summer 2014 Atlanta, GA Genentech Inc., South San Francisco, CA Partnered with the Product and Sales Summer Associate, Summer 2014 Business Development Intern, Summer 2014 teams to develop collateral for recent Performed fundamental analysis Assisted deal teams in four licensing, and upcoming product releases . Drove of domestic equities for $9B fund . acquisition, and collaboration deals by the creation and operationalization of Constructed buy, sell, hold, and pass conducting scientific, legal and financial customer case studies in coordination recommendations for 30+ stocks, due diligence, drafting term sheets, with Sales Senior Leadership, Corporate and presented them to the portfolio and supporting negotiations in Marketing, and Customer Success . managers . Immunology and Infectious Diseases spaces . Evaluated potential partnerships Omada Health, San Francisco, CA Tiger Global Management, and deal structures to enable Business Development Consultant, New York, NY microbiome research and presented Summer 2013 Analyst Intern, Spring Semester 2014 recommendations to senior leadership . Collaborated with Co-Founders, VP of Worked 10-20 hours per week during Marketing, and VP of Sales to develop the spring semester . Conducted primary Frankel Group LLC, New York, NY a multi-year business plan strategy: research, reference checks and built Senior Associate, 2012-2013 outlined sales process and target financial models for equity investment Associate, 2011-2012 market, and developed pricing strat- ideas in various industries . Analyst, 2010-2011 egy . Assessed market competition and Provided strategic recommendations product positioning, and established NCDR, LLC (dba Kool Smiles), Atlanta, GA to guide pharmaceutical and biotech strategic partnerships with wellness Business Development Manager, 2012-2013 companies’ global R&D investments . companies and benefits consultants to Senior Financial Analyst, 2010-2012 Developed 9-year renal disease business leverage synergies among product and Led team of 7 during pilot and expansion strategy totaling $8B in revenue for service offerings . of orthodontic program . Created Fortune 50 pharmaceutical company; pricing, roll-out, and capital spending analyzed market research and secondary Mercer, San Francisco, CA strategies and presented recommenda- data to develop $2B revenue model Senior Associate, 2013 tions to executive management team . for immune-based renal diseases . Associate, 2011-2013 After receiving approval, grew program Created investor presentation for Senior Analyst, 2010-2011 from pilot in 2 offices representing a development stage biotech and Analyst, 2008-2010 $200,000 of revenues to 14 offices collaborated with CEO to determine Consulted self-funded employers representing $2M of revenues in 6 differentiating properties of novel (ranging from 2,000 to 150,000 months . drug and appropriate level of clinical employees) in solving major healthcare data disclosure for a non-scientific service, cost, and administration issues . Summit Partners, Palo Alto, CA audience . Led team in conducting Proposed solutions to address the Associate, 2007-2009 150 primary interviews targeting short and long term implications Originated and executed healthcare physicians, patients, and payers; of healthcare reform, and managed private equity investments . Led synthesized findings to develop cross-functional teams of experts in reimbursement, market, regulatory, orphan disease business strategy for law, pharmacy, and wellness as well and financial due diligence efforts . Fortune 50 pharmaceutical company . as vendor account managers and Conducted primary interviews, wrote implementation leads . Led the West investment memorandums, and mod- Coast offices in Data Warehouse eled deal return scenarios . Originated & Healthcare Analytics sales and 11 Letters of Intent representing $1B implementations . of Summit Partners’ capital .

23 Charlie A. Robinson Alexander V. Rupert Ankit Saxena [email protected] [email protected] [email protected] University of Pennsylvania, Dartmouth College, Hanover, NH Indian Institute of Technology (IIT), College of Arts & Sciences, Philadelphia, PA A .B ,. Summa Cum Laude, Chemistry and New Delhi, India BA, Cum Laude, English, 2008 Psychology, 2007 Dual Degree Bachelor and Master of Technology, Biochemical Engineering & Biotechnology, 2009

An opportunity to improve healthcare An opportunity with a hedge fund An opportunity to improve the interactions delivery through innovations in care investing across the capital structure. among various stakeholders within the management, informatics, patient healthcare value chain. engagement, data connectivity, and King Street Capital Management, insurance programs. London, UK Strategy& (formerly Booz & Company), Summer Associate, 2014 New York, NY Aetna Accountable Care Solutions, Generated investment ideas in the Associate, Summer 2014 Boston, MA paper and packaging and European Analyzed network strategy at a major Product Strategy Intern, Summer 2014 airlines spaces, presenting recommen- health insurer to achieve 15% medical Developed product concept to dations to the Investment Committee . cost saving for launch of a $5B consumer- support accountable care organizations, Met with management teams and directed business . Developed hypothesis including recommendations for tech- consulted industry experts to discover and analysis framework for savings in nology utilization, partnerships, and business risks and opportunities . Durable Medical Equipment, and implementation; supported development Created detailed operating models Specialty Care Services . of external partnerships designed to and analyzed capital structure enhance accountable care organizations . alternatives including rights offerings . SQZ Biotechnologies, Boston, MA Marketing Head, 2013-2014 The Advisory Board Company, Taconic Capital Advisors, New York, NY Developed two-part marketing strategy: Washington, DC / Austin, TX Associate, 2011-2013 1) Outbound marketing initiatives such Dedicated Advisor, Performance Worked with fund Partners on distressed as vendor shows that resulted in 30 Technologies, 2011-2013 credit opportunities and long-short active customers within first 8 months Worked on a team that launched equity positions . Developed recovery of operations; 2) Inbound marketing a new business intelligence tool model to determine value of unsecured initiatives via SEO and customer analytics designed to empower a data-driven claims at various entities in the (impressions, click-through rate, and approach to physician network American Airlines capital structure . conversions), that resulted in 2x development; analyzed large data Investigated Monster Beverage Corp’s growth in traffic in 2 months . sets, developed work plans, and convenience store sales strategy to provided execution support for model growth opportunity . Assessed Novartis Vaccines & Diagnostics, program improvements . widespread media reports regarding Raleigh, NC health hazards associated with energy Global Value Chain Manager-Influenza Associate, Analyst, & Senior Analyst, drinks . Research led to a $50M equity Portfolio, 2011-2013 Research & Insights, 2008-2011 long position . Global Technical Leadership Program Developed hospital strategies for clinical Associate, 2009-2011 technology adoption and specialty The Blackstone Group, New York, NY Led planning, execution and issue program development; used pro-forma Analyst, 2009-2011 management for portfolio comprising modeling to inform technology and Collaborated with management teams 6 influenza vaccine products accounting infrastructure investments; led a team of automotive and insurance companies for 25% of revenue for the division . specializing in minimally invasive surgery, to create financial models and business Managed cross-functional projects obesity, and chronic disease manage- plans for corporate restructurings . in supply chain, manufacturing, ment . Formulated strategies to negotiate engineering, and finance across with stakeholders and regulators . U .S .A ., U .K ., Italy, India, and Germany . Wharton Center for Health Management & Economics, Philadelphia, PA J.P. Morgan, New York, NY Researcher, 2007-2009 Analyst, 2007-2009 Explored success and failure of venture Performed credit reviews for J .P . capital-funded healthcare companies; Morgan’s technology, media, and tele- published article in Health Affairs, communications loan portfolio . Wrote January 2009 . a weekly update for report to CEO on restructuring situations .

24 Matthew L. Schulz Bedir W. Shather, Adam R. Sinensky [email protected] [email protected] Carnegie Mellon University, Pittsburgh, PA M.D. University of Pennsylvania, Philadelphia, PA B .S ., University Honors, Business Administration B .S .E, Magna Cum Laude, Bioengineering, 2005 (Finance), 2008 [email protected] University of Leeds Medical School, Leeds, UK M D. ., 2009 Imperial College London, London, UK B Sc. . Medical Sciences and Management, 2007

An opportunity with a private equity An opportunity to help build an A role blending strategy and operations fund investing in the healthcare sector. innovative health care company for a provider focused healthcare through a business development role. IT solution. Teladoc, Greenwich, CT MBA Associate, Summer 2014 J.P. Morgan, San Francisco, CA Valence Health, Chicago, IL Constructed business plan and projection Summer Associate in Health Care Product Definition Intern, Summer 2014 model for a contemplated behavioral Investment Banking, Summer 2014 Established standard operating health product offering . Assessed Advised clients in the biotechnology, procedures for demonstrating suite acquisition opportunities and evaluated medical devices and diagnostics indus- of health provider IT products to new revenue models . Sourced potential tries . Performed financial analyses in- customers . Wrote requirements investors and negotiated term sheets cluding DCF and trading comparables documentation for development of 5 for Series F fundraise . for an $80M private placement round new product features leveraging Agile for an innovative diagnostics company . process . Supported upcoming product Altaris Capital Partners, New York, NY Performed sum of the parts DCF valua- user experience overhaul, including Associate, 2011-2013 tion as part of a defense strategy for development of user personas and Assessed and executed new healthcare an $8 .9B biotechnology company . Led interface redesign . acquisition opportunities . Drafted the creation of a buy-side M&A ideas transaction documents, arranged debt pitchbook, conducting due diligence Navigant Consulting Life Sciences financing, managed diligence work on over 30 potential acquisition Advisory Services, New York, NY / flow, and built investment models . targets for a $1 .2B biotechnology San Francisco, CA Monitored existing portfolio companies company . Associate Director, 2013 by attending board meetings, Managing Consultant, 2010-2013 performing valuation analyses, and Life Technologies, San Diego, CA Senior Consultant, 2009-2010 reviewing strategic opportunities with & London, UK Commercial and business development management . Assisted in fundraising Associate to the Chief Medical Officer, consultant for life sciences organizations . process for Altaris’ third fund . Closed 2012-2013 Managed internal teams and external four deals including two LBOs, one Part of a clinical team tasked with relationships for up to 8 concurrent add-on, and one exit . identifying target areas for product client engagements . Launched San development . Worked with R&D team Francisco office as day-to-day leader; Leerink Partners / Merrill Lynch, to build models to identify target integral in growth to 7 employees and New York, NY biomarkers, leading to the creation ~10% of practice’s revenues within Analyst, 2008-2011 of 3 oncology panel tests used by a first year . Led multiple long-term Analyzed equity, equity-linked and number of academic medical centers . client relationships, encompassing debt financing alternatives, merger Led the development of a clinical multiple follow-on projects . consequences, private equity invest- marketing campaign for the compa- ments, and IPO scenarios for compa- ny’s first appearance at the ASCO . ZS Associates, New York, NY nies across the healthcare industry . Associate Consultant, 2007-2009 Joined a group of over 20 investment National Health Service, London, UK Associate, 2005-2007 bankers from Merrill Lynch who Senior house physician (resident) 2009-2011 Provided sales and marketing strategic assumed leadership of the investment Prioritized, diagnosed, and treated advice to top pharmaceutical and banking platform at Leerink Partners . inpatient admissions across a variety biotechnology companies . Managed Closed four deals including three M&A of specialties in internal medicine client relationships and internal project transactions and one equity offering . and general surgery . Delivered teams as large as 5-6 employees globally clinical results while working to and officially mentored 3 junior tight deadlines in a highly pressured employees . environment .

25 Laura G. Swearingen Tejus B. Ujjani Daniel P. [email protected] [email protected] van den Bergh Davidson College, Davidson, NC Boston University – School of Management, B .A ., Economics, 2009 Boston, MA [email protected] B S. ., Magna Cum Laude, Business, 2004 Cornell University, Ithaca, NY B .S ., Biological Engineering, 2007

An opportunity to build successful An opportunity to research and evaluate An opportunity to further innovation businesses through health care investments in public and private health in healthcare technology, whether as focused private equity investing. care companies. an investor or operator.

NaviMed Capital, Washington, DC Valo Group, Philadelphia, PA Longitude Capital, Menlo Park, CA Summer Associate, Summer 2014 Investment Analyst Intern, Summer Associate, Summer 2014 Worked with founding partner of Summer 2014-Present Built the foundation and investment healthcare-focused growth equity Evaluated equity and credit invest- strategy for the $710M firm’s newly- fund to manage due diligence process ments in both health care and retail formed health IT vertical . Created and for an investment in the roll-up of companies for value-oriented, long / executed a thesis-based deal sourcing several healthcare services companies . short hedge fund . Performed market effort by mapping the sector, its Built financial model, developed financing sizing, researched SEC filings and built themes, and its 1,000+ companies . materials to raise capital and worked detailed financial models to inform Established the vertical’s advisory directly with management teams . analyses and provide recommenda- network of 20+ former entrepreneurs, Researched industry landscape, tions directly to portfolio manager . industry leaders, and investors . identifying 20+ investment opportunities . Proactively sourced 8 investment Deloitte Corporate Finance (Health Care opportunities and performed due HarbourVest Partners, Boston, MA & Life Sciences Practice), New York, NY diligence . Worked directly with partners Direct Investment Associate, 2011-2013 Vice President, 2011 – 2013 and managed two junior interns . Sourced, evaluated and monitored Associate, 2008 – 2011 growth equity, buyout, and mezzanine Analyst, 2006 – 2008 Safeguard Scientifics, Wayne, PA private equity investments for Direct Provided financial advisory services to Associate, 2011-2013 Investment Group with ~$1 5B. dedicated public and private health care clients Performed 8 venture capital capital . Evaluated 150 new opportunities regarding mergers, acquisitions, deployments and an exit totaling and performed due diligence, created divestitures/carve-outs and joint $850M+ in transaction value in financial analyses and presented 13 ventures . Led deal team in advising biopharma, medtech, diagnostics, and prospective investments to Investment not-for-profit health care system ($7B health IT . Performed due diligence Committee, gaining approvals for 5 Revenue) in execution of multiple on investment opportunities . Drafted initial investments (1 healthcare services acquisitions and joint ventures (e .g . investment memos and term sheets . company) . Active board involvement surgery centers, radiology, radiation Built financial models and cap tables . on 3 portfolio companies . Completed oncology, dialysis, anesthesia, and Rebuilt the firm’s backbone capital 2 follow-ons and refinancing for group physician practices) . deployment and returns model . ReCommunity, creating the largest Worked with leadership of portfolio independent recycling company in AT&T Corporate, Financial Leadership companies on strategic projects . the U .S . Program, Bedminster, NJ Corporate Finance Specialist, 2005-2006 EuroConsult, New York, NY Wells Fargo Securities, Charlotte, NC Associate, 2004-2005 Associate, 2009-2011 Healthcare Investment Banking Analyst, One of seven undergraduates Led cross-border M&A transactions for 2009-2011 recruited nationwide for executive private equity and Fortune 500 clients Top 10% of analyst class . Analyzed development program with rotational in pharma and medtech . Managed a companies using comparable company, assignments . Strategic Venture Fund – team of analysts . discounted cash flow, accretion/dilution, Built valuation models and evaluated merger and leveraged buyout analyses startup companies as potential invest- Citigroup, London, UK / New York, NY for M&A transactions and debt and ments for AT&T’s venture capital fund . Analyst, 2007-2009 equity financings for life sciences Corporate Strategy - Supported Active participant on deal teams companies . Director in analyzing business models originating and executing M&A around new, confidential media transactions in the healthcare sector technologies for CEO, David Dorman . across the U S. ,. European and emerging markets .

26 David S. Wagner Ying Yang Rada Yovovich [email protected] [email protected] [email protected] Yale University, New Haven, CT Fudan University, Shanghai, China University of Chicago, Chicago IL B .A ., Economics, 2009 B A. ., Economics, B .A ., Law, 2007 AB Fundamentals: Issues & Texts, 2006 M A. ., Economics, 2010

A direct investing opportunity with An opportunity in strategy or business An opportunity focused on innovation exposure to the healthcare sector. development to bridge developed in health care delivery, particularly at and emerging markets in the healthcare the point of service, with experience in Fidelity Investments, Boston, MA industry. big data analytics, supply chain, clinical Summer Equity Analyst, Summer 2014 and non-clinical process improvement, and revenue cycle. Performed fundamental equity analysis Novartis AG, Basel, Switzerland on domestic stocks in the retail sector . MBA intern, Corporate Strategy, The Children’s Hospital of Philadelphia, Constructed buy/sell recommendations Summer 2014 Philadelphia, PA for four stocks and pitched them Helped with 5-year strategic planning Summer Intern, 2014 to portfolio managers . Developed across all divisions and geographies in Worked with the VP of Medical Affairs and presented industry overview Novartis . Coordinated a global project to develop a program for physician presentation of discount retail sector on real-world outcomes across US, leadership education, including a to portfolio managers and President Brazil, UK and Germany . Analysis needs assessment, content design, of Equity Division . influenced senior decision making, delivery model, and communication changed forecast, and shifted strategy . Worked collaboratively PAR Capital Management, Boston, MA spending . to integrate the perspectives of a Summer Analyst, Summer 2013 comprehensive variety of stakeholders Member of investment team at long- McKinsey & Company, New York, NY / throughout the academic medical center, short equity hedge fund with over Shanghai China ranging from nurse and physician staff $3 .5B in assets . Constructed financial Associate, 2013 to the senior leadership team . models and performed detailed analyses Business Analyst, 2010-2012 by developing bottom-up forecasts Distinctive analyst directly promoted athenahealth, Watertown, MA to assess sensitivity to key drivers and to Associate and the only transferee Senior Manager, 2011-2013 to identify upside/downside potential from Greater China to the US in 2012 . Supported senior leadership team as of investment opportunities . Focused on multinational pharmaceutical companies . Key projects included strategic subject matter expert on revenue cycle big data performance Putnam Associates, Boston, MA commercial excellence (e .g ., sales force measurement, analysis, and reporting Consultant, 2009-2013 effectiveness, marketing strategy), across athena client base representing Advised leading pharmaceutical and business development (e .g ., M&A over 50,000 physicians . Delivered biotech clients on growth strategies, target screening, licensing), and performance improvement reports, therapeutic area strategies, and pricing emerging market strategy (e .g ., including implementation plans and reimbursement strategies, in both entry and expansion strategy, local and detailed impact projections to international and domestic markets . partnership) . Extensive field experience organizations ranging from 2-physician Constructed financial models and with sales representatives and physicians . practices to 93-hospital health systems . Monte-Carlo simulations to forecast value of pricing and contracting Huron Consulting Group, Chicago, IL strategies, potential biosimilar Manager, 2006-2011 competition, and impact of generic Delivered supply chain, materials competition . Awarded 2011 Putnam management, and strategic sourcing MVP honor as distinction of top cost management strategies to senior performance out of all employees . leadership teams at client health systems ranging from single hospitals to 70- facility national healthcare institutions . Conducted cost savings strategies worth as much as $65M annually recurring savings, including identifica- tion, assessment, implementation, and ongoing monitoring efforts .

27 2014 Internship Sponsors

The following organizations CRESSEY & CO. MOUNT KELLETT CAPITAL MANAGEMENT provided internships for Health Care Chicago, IL New York, NY Management Students in Summer, 2014. DAVITA HEALTHCARE PARTNERS NAVIMED CAPITAL Denver, CO Washington, DC

DELOITTE CONSULTING NOVARTIS AG AETNA ACCOUNTABLE CARE SOLUTIONS New York, NY Basel, Switzerland Boston, MA Hartford, CT FIDELITY INVESTMENTS PFIZER Boston, MA New York, NY ALBRIGHT STONEBRIDGE GROUP Washington, DC FITLY PUTNAM INVESTMENTS Philadelphia, PA Boston, MA APPLE TREE PARTNERS Princeton, NJ GENENTECH INC. QUANTIA INC. South San Francisco, CA Waltham, MA ATHENAHEALTH Watertown, MA GENZYME, A SANOFI COMPANY RAYMOND JAMES Cambridge, MA Nashville, TN AUGMEDIX San Francisco, CA GLENHILL CAPITAL TELADOC New York, NY Greenwich, CT BANK OF AMERICA MERRILL LYNCH Palo Alto, CA GOOGLE UNIVERSITY OF COLORADO, Mountain View, CA DEPARTMENT OF MEDICINE BECTON DICKINSON Aurora, CO Franklin Lakes, NJ HEALTH ENTERPRISE PARTNERS New York, NY UNIVERSITY OF PENNSYLVANIA BIOGEN IDEC HEALTH SYSTEM Cambridge, MA HEALTH ESSENTIALS LLC PHILADELPHIA, PA Santa Ana, CA BOOZ & COMPANY (NKA STRATEGY&) UNIVERSITY OF PITTSBURGH New York, NY HOSPITAL OF THE UNIVERSITY OF MEDICAL CENTER PENNSYLVANIA, CENTER FOR SURGERY Pittsburgh, PA THE BOSTON CONSULTING GROUP AND HEALTH ECONOMICS Shanghai, China Philadelphia, PA VALENCE HEALTH Chicago, IL BRISTOL-MYERS SQUIBB INFOSYS LIMITED Plainsboro, NJ Pune, India VALO GROUP Philadelphia, PA CASTLIGHT HEALTH JOHNSON & JOHNSON – San Francisco, CA JANSSEN BIOTECH INC. WALMART ECOMMERCE Horsham, PA San Bruno, CA CEDARS-SINAI HEALTH SYSTEM Los Angeles, CA J.P. MORGAN WELLS FARGO SECURITIES San Francisco, CA San Francisco, CA CELGENE CORPORATION Summit, NJ KAISER PERMANENTE ZALORA Oakland, CA Jakarta, Indonesia CELGENE CELLULAR THERAPEUTICS Warren, NJ KING STREET CAPITAL MANAGEMENT London, UK THE CHILDREN’S HOSPITAL OF PHILADELPHIA LONGITUDE CAPITAL Philadelphia, PA Menlo Park, CA

CITADEL INVESTMENT GROUP MCKINSEY & COMPANY New York, NY Palo Alto, CA Washington, DC CORNERSTONE INVESTMENT PARTNERS Atlanta, GA Atlanta, GA Moscow, Russia

MEDTRONIC Northridge, CA Minneapolis, MN

28 2014 Health Care Program Mentors

Mentors are leaders and senior managers RYAN BERGER WILLS CHANDLER in the health care field who have agreed Senior Business Analyst Vice President of Health System Alliance to provide career and professional Hearst Health Innovation Lab CVS Caremark development advice and guidance Los Angeles, CA Cumberland, RI to Health Care Management Students. ALEXIS BERNSTEIN DEEP CHARAN, MD Director, Strategy & Operations, Resident Physician Accountable Care Solutions UCLA Aetna Los Angeles, CA Boston, MA SEBASTIAN AGUILAR GARCIA THIERRY CHAUCHÉ Associate DEEPA BHAT Executive Director, A .T . Kearney Product Manager Business Planning & Analysis Mexico City, Mexico Genentech Novartis Pharmaceuticals South San Francisco, CA East Hanover, NJ SHEENA ASHOK Senior Consultant MITCHELL BLUTT, MD EMILY COUEIGNOUX CHEN Kaiser Permanente-Southern California CEO Senior Manager, Market Planning Permanente Medical Group (SCPMG) Consonance Capital Seattle Genetics Pasadena, CA New York, NY Bothwell, WA

VIKRAM D. BAKHRU, MD DANIEL BRANCO MARK CHIN Chief Medical Officer Founder & CEO Vice President First Opinion DMBranco Healthcare Investments & Longitude Capital San Francisco, CA Advisory/Medicinia Digital Medicine Menlo Park, CA São Paulo, Brazil TONY BALDA BRIAN G. CHOI, MD President & COO SAM BRASCH Associate Professor of Medicine & Radiology Medicomp, Inc . Director George Washington University Melbourne, FL Kaiser Permanente Ventures Washington, DC Oakland, CA JOHN BARKETT EDDIE CISNEROS Director of Product Marketing JOHN BRODSKY Vice President, Business Development and Policy Affairs President DAVITA HEALTHCARE PARTNERS Towers Watson Exchange Solutions Fairmount Capital Advisors, Inc . Chicago, IL Washington, DC Philadelphia, PA RYAN COCHRAN MEGAN UNTALAN BARKETT LUCAS BUCHANAN Associate Chief of Staff to CEO Executive Vice President, New Leaf Venture Partners The Advisory Board Company Corporate Development and New York, NY Washington, DC Commercialization; Executive in Residence Silk Road Medical, Inc .; Warburg Pincus BRETT COHEN PETER R. BARNETT, DMD Sunnyvale, CA Corporate Vice President President Fresenius Medical Care Star Ranch Dental ALEX BUZIK Waltham, MA Plano, TX Managing Director MTS Health Investors CAROLYN COLACICCO GRANT BECHTOLD New York, NY Senior Manager Vice President of Business Operations / TriVascular Corporate Development ELIZABETH J. CAMPBELL Santa Rosa, CA Medsurant Holdings, LLC Principal (portfolio company of New Capital Partners) SV Life Sciences Advisors, LLC DANIEL J. CURRAN, MD Denver, CO Boston, MA Vice President, Therapeutic Area Lead Takeda Pharmaceutical Company JAMIL BEG NICOLE CARKNER Cambridge, MA Director, Business Development Executive Director Sage Therapeutics, Inc . Quad City Health Initiative JAY DESAI Cambridge, MA Davenport, IA Entrepreneur PatientPing ALI BEHBAHANI, MD EDWARD CHAN Boston, MA Partner Senior Associate NEA NaviMed Capital SALIL V. DESHPANDE, MD Chevy Chase, MD Rosslyn, VA Chief Medical Officer UnitedHealthcare Community Plan of Texas ERIC BELL Houston, TX Senior Director Intellectual Ventures Seattle, WA continued on next page

29 CARRIE HIEBELER Health Care Program Mentors Senior Investment Officer Ventas, Inc . Chicago, IL PITAMBER “PITOU” DEVGON, MD SARAH FREW Co-Founder Director, Business and VLAD HOGENHUIS, MD Creative Vascular, Inc . Commercial Development Senior Vice President, Global Franchise Philadelphia, PA Tetralogic Pharmaceuticals Leader CardioVascular Malvern, PA GlaxoSmithKline CHRIS DUKE Brentford, UK Executive Director MIHIR C. GANDHI International Commercial Relations Director, SAM HOLLIDAY NPS Pharmaceuticals Healthcare Venture Investments Vice President, Corporate Development Bedminster, NJ AVIA Innovation Accelerator & Strategy Chicago, IL Everyday Health CATHY K. EDDY New York, NY President MICHAL GATTNAR Health Plan Alliance Managing Director TODD HOLMES Irving, TX Pavis Capital Director Mill Valley, CA Gurnet Point Capital BRANDON EINSTEIN Boston, MA Associate SIMEON J. GEORGE, MD Goldman Sachs Partner BRIAN HOLZER New York, NY SR One Ltd Senior Vice President, San Francisco, CA Diversified Businesses RAMI ELGHANDOUR Allegheny Health Network Chief Business Officer KYLE GILBRIDE Pittsburgh, PA Nevro Senior Associate Menlo Park, CA HEALTHAGEN, a subsidiary JARED HOPKINS of Aetna Director MYRIAN EXUME New York, NY Strategic Finance and Director, Global Commercialization Business Consulting Bristol-Myers Squibb LETICIA LAZARIDIS GOLDBERG University of Michigan Princeton, NJ Investment Management Health System Earnest Partners - Brazil Office Ann Arbor, MI DANIEL FAGA Rio de Janeiro, Brazil Principal NOUHAD HUSSEINI Centerview Partners BRIAN P. GOLDSTEIN, MD Senior Director, San Francisco, CA Executive Vice President Business Development and Chief Operating Officer Regeneron Pharmaceuticals MING FANG UNC Hospitals Tarrytown, NY Principal Chapel Hill, NC Safeguard Scientifics, Inc . EMILY COOPER JANVEY Wayne, PA VIKAS GOYAL Vice President Associate TPG Special Situations Partners MICHAEL FAZEKAS SR One San Francisco, CA Vice President Cambridge, MA Flexpoint Ford, LLC MAGGIE HILL JARRETT Chicago, IL TODD GUREN Senior Manager, Corporate Strategy Product Development Manager & Business Development EVAN S. FIELDSTON, MD Providence Health Plans McKesson Assistant Professor of Pediatrics, Portland, OR Denver, CO Perelman School of Medicine; Attending Physician General Pediatrics, PHILIP GUTRY PRASHANTH JAYARAM Director Care Model Innovation, Principal Healthcare Analyst The Children’s Hospital of Philadelphia MPM Capital Citadel Group Philadelphia, PA South San Francisco, CA New York, NY

DOUGLAS C. FISHER, MD JOHN HARRIS VIVEK K. JAYARAMAN Partner Principal Vice President – InterWest Partners DGA Partners Global Sales & Marketing Menlo Park, CA Bala Cynwyd, PA TriVascular, Inc . Santa Rosa, CA PETER FISHMAN BOSUN HAU Founder Partner TRACY K. JOHNSON Tolograph MVM Life Science Partners Vice President New York, NY Boston, MA Health Strategies and Solutions Philadelphia, PA AARON FLINK DAVID HECHT Sr . Manager, Corp . Strategy Vice President FABIO ALEXANDRE JUNG and Business Development Formation Capital Director/Investment Banking Brazil McKesson Alpharetta, GA Deutsche Bank San Francisco, CA São Paulo, Brazil PHIL HEIFETZ CHRIS FRANCK President and CEO KARL M. KELLNER Partner, Life Sciences & Health Care EyelC, Inc . Director Deloitte Consulting, LLP W . Conshohocken, PA McKinsey & Company, Inc . Parsippany, NJ New York, NY

30 RON C. KERO LAUREN LISHER WESLEY NURSS Vice President, Senior Director Associate Business Development & Operations RelayHealth/McKesson Corporation ISI Group VHA West Coast Insurance Emeryville, CA New York, NY & Financial Services Renton, WA WENDY LIU JAMES O’CONNELL Vice President Principal RUHI KHAN HealthCare Royalty Partners Safeguard Scientifics, Inc . Vice President, Business Development Stamford, CT Wayne, PA Acorda Therapeutics Hawthorne, NY MARK A. LYLES, MD JENNIFER O’NEILL Chief Strategic Officer Brand Manager, Effient DAVID KIBBE Medical University of South Carolina Daiichi Sankyo Inc . Divisional Vice President, Acute Care Charleston, SC Parsippany, NJ Universal Health Services King of Prussia, PA CAROLYN MAGILL CARY PFEFFER, MD Senior Vice President, Partner MIKE KIJEWSKI Payer Strategy & Operations Third Rock Ventures Founder Evolent Health Boston, MA Gamma Basics Arlington, VA Carlsbad, CA GARY M. PHILLIPS, MD JEFFREY D. MARRAZZO Senior Vice President and JOYCE KIM President and CEO Chief Strategy Officer Senior Managerial Consultant Spark Therapeutics Inc . Mallinckrodt Pharmaceuticals Kaiser Permanente Ventures Philadelphia, PA Hazelwood, MO Oakland, CA ALISON MARX JOHN PICASSO STEPHEN KIM Operating Officer, Dept . of Pediatrics Senior Associate Associate The Children’s Hospital of Philadelphia Fifth Street Management LLC Goldman, Sachs & Co . Philadelphia, PA White Planis, NY New York, NY GREGG MCCONNELL SALLY POBLETE RYAN KIRKPATRICK Sr . Manager, Business Development Founder and CEO Partner Pfizer Wellthie Inc . Colorado Impact Fund New York, NY New York, NY Denver, CO ROBERT C. MCDONALD, MD LEN PODOLSKY DAVE KONCIAK President Director of Operations Director, Strategic Analytics Aledo Consulting, Inc . Connolly, LLC Bristol-Myers Squibb Indianapolis, IN Conshohocken, PA Lawrenceville, NJ REGAN MURPHY AMIKA PORWAL ADAM M. KOPPEL, MD, PHD Chief of Staff / Client Manager Senior Associate Chief Strategy Officer & Senior Vice President Valence Health Booz & Company Biogen Idec Chicago, IL Chicago, IL Boston, MA HAREESH NAIR KEVIN PYUN MICHELLE LEE Vice President Managing Director Consultant Quadria Capital Investment Mgmt . Pte Ltd Consonance Capital Investors Kaiser Permanente Performance Excellence Singapore New York, NY San Francisco, CA DAVID B. NASH, MD LISA RAMON RICHARD LEE, MD Dean, Jefferson School of Population Health Health Systems and Services Expert Assistant Professor Thomas Jefferson University for Latin America Weill Cornell Medical College Philadelphia, PA McKinsey & Company New York, NY Mexico City, Mexico TY NELSON ELIZABETH LEIDERMAN, MD Executive Vice President Operations LINDSAY RAND Vice President Health Carousel LLC Senior Manager, Strategic Initiatives Office Nomura Cincinnati, OH University of Chicago Medicine New York, NY Chicago, IL PRASHANT NIKAM ADAM LESSLER Director, Global Commercial Leader, DONNA BRADY RAZIANO, MD Engagement Manager Mozobil & Legacy Brands Chief Medical Officer McKinsey & Company Sanofi Mercy Home System, Philadelphia, PA Cambridge, MA Mercy Home and Community Health Services MICHAEL LI TATIANA NIKITINA Philadelphia, PA Portfolio Manager Chief Marketing Officer American Century Investments xG Health Solutions ERIC REDLINE Kansas City, MO New York, NY Vice President Client Delivery Pharma Metrics OSCAR LIN PRIYA NILEKANI Fort Washington, PA Analyst Senior Managerial Consultant Axial Capital Kaiser Permanente JOSHUA RESNICK, MD New York, NY Oakland, CA Venture Partner, Atlas Venture; CEO, Ataxion Therapeutics Cambridge, MA

continued on next page

31 BEN RHEE DAVID SILK AMANDA HOPKINS TIRRELL Senior Manager – Life Sciences Strategy Director Chief Operating Officer Accenture Digital Acceleration, US Marketing Georgia Regents Medical Associates, Philadelphia, PA Pfizer Medical College of Georgia New York, NY Augusta, GA JAMES RHODES Senior Consultant ANNE SISSEL ERIC TRÉPANIER Deloitte Consulting LLP Vice President Vice President, Dallas, TX Dean Bradley Osborne Commercial Clinical Strategy & Analytics San Francisco, CA WebMD/Medscope JAMES F. RICHTER New York, NY Vice President JONTHAN SOLOMONS Business Development President & CEO JOHN URQUHART RedMed Tabor Children’s Services Senior Associate Paoli, PA Philadelphia, PA HealthCare Royalty Partners Stamford, CT SAFIA K. RIZVI MAUREEN A. SPIVACK Managing Director Managing Director LISA VARSHNEY UCB India Private Limited KPMG Corporate Finance LLC Associate Partner Mumbai, India New York, NY Rosetta Marketing Strategy & Insights Practice EDMONDO J. ROBINSON, MD BHUVAN SRINIVASAN New York, NY Associate Chief Medical Officer, Associate Physician in Chief KKR DAVID WALTON Christiana Care Health System Mumbai, India Chief Commercial Officer Wilmington, DE AgaMatrix JAMES STANFORD Salem, NH PAMELA RODMAN Principal Administrative Director Fitzroy Health JASON WEIDMAN Columbia University Upper Montclair, NJ Vice President and General Manager, New York, NY Medtronic Coronary Vascular MEIR STEIN Medtronic BENJAMIN ROOKS Director of Marketing Development Santa Rosa, CA Managing Director Satellite Healthcare ST Advisors, Inc . San Jose, CA CHRIS WILKERSON San Francisco, CA President JÉRÔME STEVENS, MD EquipSystems, LLC MICHAEL ROVINSKY CEO New York, NY Executive Director, Strategic Planning Patientys Kaiser Permanente of the (subsidiary of Direct Medcica Group) JOHN WINKELMAN Mid-Atlantic States Boulogone, France President Rockville, MD Winkelman Associates Inc . SCOT STEVENS Irvine, CA ANIL SAGGI Public Equity Partner M&A Director Orbi Med Advisors LLC ANDREW W. WONG Novartis New York, NY Vice President, Business Development Stockholm, Sweden SciClone Pharmaceuticals, Inc . PATRICK SULLIVAN Shanghai, China DAVID SCHUPPAN Vice President Partner GMT Capital Corp . DANIEL YIP Cressey & Company LP New York, NY Senior Director, Global Marketing Chicago, IL Intercept Pharmaceuticals RUTH SUTER New York, NY SVEN SEYFFERT Senior Director, Senior Business Director Market Access and Patient Services STEPHEN E. YODER, MD Medtronic BioMarin Pharmaceutical Inc . Global Lead, CV/Metabolic Search Singapore Novato, CA & Evaluation, Bus . Dev . Bristol-Myers Squibb AMIT B. SHAH, MD VIC TANDON Princeton, NJ Associate Principal Sr . Manager, McKinsey & Company Health and IT Strategy ELLEN S. YOON New York, NY West Health Institute Global Health Care Subject Matter Expert La Jolla, CA IBM Corp . ANKIT SHAH New York, NY Sr . Marketing Manager JARED TEO Intersect ENT Sr . Program Officer KEELY ZIPP Menlo Park, CA California Health Care Foundation Director Oncology Operations, San Francisco, CA Global Oncology Franchise JONATHAN SHANNON GlaxoSmithKline Executive Director PAUL V. THOMAS Collegeville, PA Universal American Business Unit Head – Biosimilars (Collaborative Health Systems) Biocon Ltd . THOMAS ZIPP Atlanta, GA Bangalore, India Global Brillinta Business Insight Lead, Brillinta SHAFINA SHEHNAZ PAUL TIRJAN AstraZeneca Vice President Vice President, Ambulatory Care Wilmington, DE Goldman Sachs & Co . Universal Health Services, Inc . New York, NY King of Prussia, PA

32 Administration

GEOFFREY M. GARRETT, PH.D. Dean, The Wharton School

HOWARD KAUFOLD, PH.D. Vice Dean and Director, The Wharton Graduate Division

SCOTT E. HARRINGTON, PH.D. Chair, Health Care Management Department, The Wharton School; Director, MBA Program in Health Care Management

JUNE M. KINNEY, M.A. Associate Director, MBA Program in Health Care Management

CHRISTINE ALESZCZYK Administrative Coordinator, MBA Program in Health Care Management

JANICE SINGLETON Administrative Coordinator, MBA Program in Health Care Management

33 Faculty EZEKIEL J. EMANUEL, M.D., PH.D. JOHN KIMBERLY, PH.D. Diane v .S . Levy and Robert M . Henry Bower Professor of Entrepreneurial Levy University Professor and Studies; Professor of Management, The Program Faculty are drawn from Vice Provost for Global Initiatives; Health Care Management, and Sociology, Professor, Health Care Management, The Wharton School the Wharton School, the School of The Wharton School Medicine, the School of Nursing, and JUNE M. KINNEY, M.A. the School of Arts and Sciences at the ROBERT I. FIELD, J.D., PH.D., M.P.H. Associate Director, Graduate Program Professor of Law at the Earle Mack School in Health Care Management; University of Pennsylvania and leading of Law and Professor of Health Management Lecturer, Health Care Management, health institutions in Philadelphia. and Policy at the School of Public Health The Wharton School Additional support is provided by the at Drexel University, Philadelphia; Lecturer, Health Care Management, JONATHAN T. KOLSTAD, PH.D. Fellows and Associates of the Leonard The Wharton School Assistant Professor, Health Care Davis Institute of Health Economics. Management, The Wharton School BRADLEY M. FLUEGEL Senior VP & Chief Strategy GARY J. KURTZMAN, M.D. Officer, Walgreens; Vice President, Life Sciences, Lecturer, Health Care Management, Safeguard Scientifics; Lecturer, EUGENIO ANESSI, PH.D. The Wharton School Health Care Management, Professor, Public Management, The Wharton School Bocconi University Graduate School THOMAS N. GILMORE, M.ARCH. of Management, Milan, Italy; JEFFREY P. LIBSON, J.D. Vice President, Lecturer and Senior Fellow, Partner, Pepper Hamilton LLP; The Center for Applied Research Inc .; Health Care Management, Lecturer, Health Care Management, Senior Fellow, Health Care Management, The Wharton School The Wharton School The Wharton School DAVID A. ASCH, M.D., M.B.A. HARI MAHADEVAN, PH.D. JOHN P. GLASER, PH.D. Executive Director, Independent Consultant; Chief Executive Officer, Penn Medicine Center for Health Lecturer and Senior Fellow, Health Systems Business Unit, Siemens; Care Innovation; Health Care Management, Lecturer, Health Care Management Professor of Medicine, The Wharton School The Wharton School Perelman School of Medicine DANIEL N. MENDELSON. M.P.P. at the University of Pennsylvania; HENRY A. GLICK, PH.D. CEO and Chairman, Avalere Health Inc .; Professor, Health Care Management, Professor of Medicine, Lecturer, Health Care Management; The Wharton School Perelman School of Medicine at The Wharton School the University of Pennsylvania; THOMAS E. BAKER, J.D. Professor, Health Care Management, William Maul Measey Professor of STEVEN A. NICHTBERGER, M.D. The Wharton School Law and Health Sciences, University Adjunct Professor and Senior Fellow, of Pennsylvania Law School; Health Care Management, MATTHEW R. GRENNAN, PH.D. The Wharton School Professor of Health Care Management, Assistant Professor, The Wharton School Health Care Management, MITESH S. PATEL, M.D. The Wharton School LAWTON R. BURNS, PH.D., M.B.A. Assistant Professor of Medicine, Perelman James Joo-Jin Kim Professor of Health School of Medicine at the University SCOTT E. HARRINGTON, PH.D. of Pennsylvania School of Medicine; Care Management, The Wharton School; Chair, Health Care Management Faculty Co-Director, Assistant Professor of Health Care Department, and Director, Management, The Wharton School Roy and Diana Vagelos Program Health Care Management Program, In Life Sciences & Management The Wharton School MARK V. PAULY, PH.D. Alan B . Miller Professor of Health Care John M . and Thomas L . Bendheim PATRICIA M. DANZON, PH.D. Management and Business Economics Professor; Professor, Health Care Celia Z . Moh Professor of Health Care and Public Policy, The Wharton School Management, Business Economics and Management and Business Economics, Public Policy, The Wharton School; The Wharton School JOHN C. HERSHEY, PH.D. Professor, Economics, College of Arts Anheuser-Busch Professor Emeritus GUY DAVID, PH.D. and Sciences of Management Science; and Associate Professor, Health Care Management, WILLIAM P. PIERSKALLA, PH.D. Health Care Management, The Wharton School Professor Emeritus The Wharton School NAOKI IKEGAMI, M.D. DANIEL POLSKY, PH.D. BENJAMIN DORANZ, PH.D., M.B.A. Professor, Keio University School of Robert D . Eilers Professor of Health Care President and CEO, Integral Molecular, Medicine, Tokyo, Japan; Senior Fellow, Management and Economics, Inc .; Senior Fellow, Health Care Health Care Management, The Wharton School; Management, The Wharton School The Wharton School Professor of Medicine, Perelman School of Medicine at the University of Pennsylvania; Executive Director, Leonard Davis Institute of Health Economics

34 DOUGLAS A. PRESENT, M.B.A. RACHEL M. WERNER, M.D., PH.D Independent Consultant; Associate Professor of Medicine, Lecturer, Health Care Management, Perelman School of Medicine at the The Wharton School University of Pennsylvania School of Medicine; Associate Professor and Senior ARNOLD J. ROSOFF, J.D. Fellow, Operations and Information Professor Emeritus, Management, Health Care Management, Legal Studies and Business Ethics; The Wharton School Lecturer, Health Care Management, The Wharton School JOHN J. WHITMAN, M.B.A. Executive Director, The TRECS Institute; STEPHEN M. SAMMUT Lecturer, Health Care Management, Lecturer and Senior Fellow, The Wharton School Health Care Management, Lecturer, Entrepreneurial Programs, SANKEY V. WILLIAMS, M.D. The Wharton School Sol Katz Professor of General Internal Medicine; Professor, CYNTHIA SCALZI, M.N., PH.D. Health Care Management, Professor Emeritus of Nursing The Wharton School and Health Care Management, The Wharton School

J. SANFORD SCHWARTZ, M.D. Leon Hess Professor in Internal Medicine, Perelman School of Medicine at the University of Pennsylvania; Professor, Health Care Management, The Wharton School

JEFFREY H. SILBER, M.D., PH.D. Director, Center for Outcomes Research, The Children’s Hospital of Philadelphia; Professor of Pediatrics and Anesthesiology & Critical Care, The University of Pennsylvania Perelman School of Medicine at values diversity and seeks talented the University of Pennsylvania; students, faculty and staff from diverse Professor, Health Care Management, backgrounds . The University of The Wharton School Pennsylvania does not discriminate JUNE KINNEY on the basis of race, sex, sexual JEFFREY A. SOLOMON, M.D., M.B.A. Associate Director, MBA Program orientation, gender identity, religion, Founding Partner, Infiniti Medical LLC; in Health Care Management color, national or ethnic origin, age, Lecturer, Health Care Management, The Wharton School disability, or status as a Vietnam Era The Wharton School Veteran or disabled veteran in the administration of educational policies, AMANDA STARC, PH.D. programs or activities; admissions Assistant Professor, policies; scholarship and loan awards; Health Care Management, athletic, or other University adminis- The Wharton School tered programs or employment . ASHLEY SWANSON, PH.D. Assistant Professor, Questions or complaints regarding Health Care Management, this policy should be directed to: The Wharton School Executive Director, Office of Affirmative Action ROBERT J. TOWN, PH.D. and Equal Opportunity Programs Associate Professor, Sansom Place East Health Care Management 3600 Chestnut Street, Suite 228 The Wharton School Philadelphia, PA 19104-6106 215 .898 .6993 (Voice) KEVIN G.M. VOLPP, M.D., PH.D. 215 .898 .7803 (TDD) Director, Center for Health Incentives and Behavioral Economics, ©2004, The Trustees of Leonard Davis Institute; SCOTT E. HARRINGTON, PH.D. the University of Pennsylvania . Professor of Medicine, Director, All rights reserved . Perelman School of Medicine MBA Program in at the University of Pennsylvania; Health Care Management, Professor, Health Care Management, The Wharton School The Wharton School Photography of Students: Stuart Watson Book Design: www.HollisterCreative.com

35 Wharton The Wharton School University of Pennsylvania

MBA Program in Health Care Management 3641 Locust Walk Philadelphia, PA 19104-6218

215 .898 .6861 fax 215 .573 .2157